Performance comparison of patient pathways in Nordic capital areas : A pilot study by Häkkinen, Unto et al.
D
IS
C
U
SS
IO
N
 P
A
PE
R
 
 
Unto Häkkinen 
Christopher Engel-Andreasen 
Fanny Goude 
Terje P. Hagen 
Marie Kruse 
Tron Moger 
Mikko Peltola 
Clas Rehnberg 
Performance comparison of patient 
pathways in Nordic capital areas  
A pilot study 
22 | 2018 
Discussion Paper 22/2018 
Unto Häkkinen, Christopher Engel-Andreasen, Fanny Goude, Terje P. Hagen, Marie Kruse, 
Tron Moger, Mikko Peltola, Clas Rehnberg
Performance comparison of patient 
pathways in Nordic capital areas 
A pilot study 
© Authors and National Institute for Health and Welfare 
ISBN 978-952-343-134-8 (online publication) 
ISSN 2323-363X (online publication)  
http://urn:fi/URN:ISBN:978-952-343-134-8  
Helsinki, Finland 2018 
THL — Discussion paper 22/2018 3 
Performance comparison of patient 
pathways in Nordic capital areas 
Foreword
This report describes part of the work that has been done for Work Package 11 (WP11) of the BRIDGE 
Health project (BRidging Information and Data Generation for Evidence-based Health policy and research, 
http://www.bridge-health.eu/). By making use of available routinely collected data, the WP11 updates and 
further develops the EuroHOPE research infrastructure (http://www.eurohope.info/), aiming to evaluate the 
performance of health-care systems in terms of outcomes, quality, use of resources and cost. This includes 
maintaining and updating the protocols for select conditions (acute myocardial infarction, acute coronary 
syndrome, stroke and hip fracture). The protocols include, e.g. inclusion and exclusion criteria, defining the 
cycle of care (when it starts, handling of transfers, follow-up, etc.), comorbidities (used in risk-adjustment) 
and specifying the process, utilisation, cost and outcome measures. National, regional and hospital-level 
indicators covering the years 2006/2009–2014 were calculated for Finland, Denmark, Hungary, Italy, 
Norway and Sweden. In 2016, the updated protocols and indicators were made available on the EuroHOPE 
web pages. National and regional indicators were published for Denmark, Finland, Hungary, Italy, Norway 
and Sweden. These have been discussed in a press release of the main results, released May 2017 (available 
at: https://thl.fi/en/web/thlfi-en/-/persistent-differences-in-health-outcomes-for-major-medical-conditions-
across-europe). 
In this report, the episode-based approach was extended to also include primary health care and social 
services in a pilot study using data from four metropolitan areas: Copenhagen, Helsinki, Oslo and 
Stockholm. Thus, the methodological innovation of this pilot study was the linking of hospital, cause-of-
death registers and data on prescribed medicines with the registers for primary and long-term care via the 
use of personal identification numbers, which makes it feasible to analyse the patients’ care pathways at 
different levels of care and for a period that covers one year before and one year after the onset of a disease. 
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Abstract 
Unto Häkkinen, Christopher Engel-Andreasen, Fanny Goude, Terje P. Hagen, Marie Kruse, Tron Moger, 
Mikko Peltola, Clas Rehnberg. Performance comparison of patient pathways in Nordic capital areas. 
A pilot study. National Institute for Health and Welfare (THL). Discussion paper 22/2018. 55 pages. 
Helsinki, Finland 2018. 
ISBN 978-952-343-134-8 (online publication) 
 
This report describes and discusses the work which extends the episode-based approach to include 
primary care and social services. The methodological innovation of this pilot study was the linking of 
national registers on hospital discharges, use of prescribed medication and causes-of-death with the 
registers for primary and long-term care via the use of personal identification numbers, which makes it 
feasible to analyse the patients’ care pathways at different levels of care and for a period that covers one 
year before and one year after the onset of a disease. 
By using linkable, patient-level data on new acute myocardial infarction, acute coronary syndrome, 
stroke and hip fracture patients from Copenhagen, the Helsinki area, Oslo and Stockholm, this pilot study i) 
extended the disease-based performance analysis to include new indicators that better describe patient care 
pathways at different levels of care; ii) described and compared the performance of care given in the four 
metropolitan areas; iii) evaluated how additional data (primary and social services, better risk-adjustment 
and new outcome measures) change the rankings of performance between the areas and discussed their 
usefulness at better understanding the reasons behind performance difference; and iv) described the trends 
in performance in the metropolitan areas. 
According to our results, differences exist in various performance indicators between the four 
metropolitan areas, but the ranking was sensitive to the risk-adjustment method. The study showed that for 
patients with mixed-care pathways across primary, secondary, tertiary and social services, a performance 
comparison with data only from the secondary and tertiary care is not always reliable for international 
comparisons. The approach studied and presented here represents an important extension in the field of 
health system performance analysis. With individual-level, routinely collected data, it is possible to 
considerably deepen the analysis and enrich the set of outcome and process indicators used for system 
performance comparison. 
 
 
Keywords: Performance comparison, patient pathways, risk-adjustment, acute myocardial infarction, acute 
coronary syndrome, stroke, hip fracture    
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Tiivistelmä 
Unto Häkkinen, Christopher Engel-Andreasen, Fanny Goude, Terje P. Hagen, Marie Kruse, Tron Moger, 
Mikko Peltola, Clas Rehnberg. Hoitopolkujen toimivuus Pohjoismaiden pääkaupunkiseuduilla - 
pilottitutkimus. Terveyden ja hyvinvoinnin laitos (THL). Työpaperi 22/2018. 55 sivua. Helsinki 2018. 
ISBN 978-952-343-134-8 (verkkojulkaisu) 
Raportissa laajennetaan aikaisempaa sairaalahoitoon perustuvaa hoitoketjujen tarkastelua 
perusterveydenhuoltoon ja vanhustenhuoltoon. Pilottitutkimuksessa on yhdistetty potilastasolla kansallisten 
sairaaloiden hoitoilmoitus-, kuolinsyy- ja lääkerekisterien tietoja perusterveyden- ja vanhustenhuollon 
rekistereitä koskeviin tietoihin. Tämä on mahdollistanut potilaiden hoitopolkujen tarkastelun hoidon eri 
tasoilla ja sektoreilla ajanjaksona, joka kattaa vuoden ennen sairauden toteamista sekä vuoden toteamisen 
jälkeen. Tutkimuksessa tarkastellaan sydäninfarkti/sepelvaltimotautikohtaus-, aivoinfarkti- sekä 
lonkkamurtumapotilaiden hoitopolkuja Helsingin alueella (Helsinki ja Espoo), Kööpenhaminassa, Oslossa 
ja Tukholmassa. Tavoitteena on i) laajentaa hoitoketjujen arviointia sisältämään uusia indikaattoreita, jotka 
aikaisempaa paremmin kuvaavat potilaiden hoitopolkuja hoidon eri tasoilla; ii) kuvata ja vertailla 
hoitoketjujen toimivuutta pääkaupunkiseuduilla; iii) arvioida kuinka perusterveyden- ja vanhustenhuollon 
sisällyttäminen tarkasteluun vaikuttaa alueiden väliseen vertailuun ja tarkastella tämän uuden informaation 
hyödyllisyyttä suoriutumiskyvyn erojen ymmärtämisessä sekä; iv) kuvata suoriutumiskyvyn ajallista 
kehitystä pääkaupunkiseuduilla. 
Tutkimuksessa havaittiin selviä eroja suoriutumiskyvyssä alueiden välillä tarkastelluissa 
potilasryhmissä mutta erot olivat herkkiä sille, miten riskivakiointi suoritettiin. Tutkimus osoitti, ettei 
pelkästään sairaalahoitoon perustuva suoriutumiskyvyn kansainvälinen vertailu ole luotettavaa. Hankkeessa 
kehitetty lähestymistapa tarjoaa tärkeän täydennyksen suoriutumiskyvyn arviointiin sekä antaa esimerkkejä 
mahdollisten uusien ja kattavampien prosessi- ja vaikuttavuusmittareiden käytön hoitoketjujen sekä 
kansallisessa että kansainvälisessä vertailussa.  
Avainsanat: Suoriutumiskyvyn arviointi, hoitoketjut, riskivakiointi, sydäninfarkti, sepelvaltimotauti-
kohtaus, aivoinfarkti, lonkkamurtuma     
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Sammandrag 
Unto Häkkinen, Christopher Engel-Andreasen, Fanny Goude, Terje P. Hagen, Marie Kruse, Tron Moger, 
Mikko Peltola, Clas Rehnberg. Jämförelse av prestationer, utfall och patientflöden i Nordiska 
storstadsområden. En pilotstudie. Institutet för hälsa och välfärd (THL). Diskussionsunderlag 22/2018. 55 
sidor. Helsingfors, Finland 2018. 
 ISBN 978-952-343-134-8 (nätpublikation) 
 
Denna rapport beskriver och diskuterar arbetet som utökar den episodbaserade ansatsen till att inkludera 
primärvård och socialtjänst. Den metodologiska innovationen av denna pilotstudie var sammanlänkningen 
av det nationella patientregistret, dödsorsaksregistret och läkemedelsregistret med register över primärvård 
och långtidsvård genom att använda individuella identifieringsnummer, vilket gör det möjligt att analysera 
patienternas flöden mellan olika vårdformer och under en period ett år före och ett år efter insjuknande av 
en sjukdom. Genom användning av sammanlänkad patientdata för nya patienter med akut hjärtinfarkt, akut 
koronarsyndrom, stroke och höftfraktur från Köpenhamn, Helsingfors, Oslo och Stockholm har denna 
pilotstudie i) utökat analysen av sjukdomsbaserade utfall till att inkludera nya indikatorer som bättre 
beskriver patientflödet mellan vårdformer; ii) beskrivit och jämfört prestationer och utfall av vård som 
givits i de fyra storstadsområdena; iii) utvärderat hur ytterligare data (primärvård och socialtjänst, bättre 
riskjustering och nya utfallsmått) förändrar rangordningen mellan områdena samt diskuterat 
användbarheten för en bättre förståelse av orsakerna till skillnader i prestationer och utfall och; iv) beskrivit 
trenderna i prestationer och utfall mellan storstadsområdena. 
 
Enligt våra resultat finns det skillnader i de olika indikatorerna över prestationer och utfall mellan de 
fyra storstadsområdena, men rankningen var känslig för val av metod för riskjustering. Studien visade att 
för patienter med ett mixat flöde mellan vårdformer som primär-, sekundär- och tertiärvård samt 
socialtjänster, är jämförelser av prestationer och utfall med data från endast sekundär- och tertiärvård inte 
alltid pålitlig för internationella jämförelser. Den ansats som använts i studien och presenteras i rapporten 
är en viktig utveckling av ämnesområdet rörande analyser av prestationer och utfall mellan hälso- och 
sjukvårdssystem. Genom att samla in och sammanställa data på individuell nivå är det möjligt att avsevärt 
fördjupa analysen och utöka indikatorer för såväl utfall som processer för att jämföra prestationer mellan 
sjukvårdssystem. 
 
Nyckelord: Jämförelse av prestationer och utfall, patientflöden, riskjustering, akut hjärtinfarkt, akut 
koronarsyndrom, stroke, höftfraktur 
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1 Introduction 
Performance-based governance requires timely and accurate patient data that span the whole care 
pathway, including health outcomes and costs. Such data are also used to support the redesign and 
evaluation of new models of health-care service delivery and contribute to the discovery and evaluation of 
new treatments. Health-care data collected by national registries and other administrative databases, which 
can be linked with each other at the individual level, are a valuable resource that can be safely used to 
improve patients’ health outcomes and the quality and performance of health-care systems. Although there 
is immense potential in these data, they are not routinely used to serve the aims of increasing service 
system performance. Thus, there is room for promoting their use to support efficiency objectives. 
Essential to health-care quality and performance assessment is the ability to follow patients as they 
progress through the health and social care system: from primary health care to specialty visits to 
hospitalisations, long-term care, home care, hospice care and death. This type of follow-up allows for a 
comprehensive view of the health-care services provided and the health outcomes generated by those 
services; it also makes it possible to uncover and assess inappropriate or avoidable service use, adherence 
to clinical guidelines, effective treatments, optimal care paths, use of resources and cost of services. 
The data included in national health information systems vary between countries in terms of coverage, 
coding and terminology, quality of data, data sharing and linkage possibilities (OECD 2015). This is the 
main challenge of every iternational performance comparison.  
A disease-based approach was adopted for evaluating the performance of European health-care systems 
(including Finland, Hungary, Italy, the Netherlands, Norway, Scotland and Sweden) as part of the 
EuroHOPE project, using the experiences of the PERFECT project. The project developed methods 
(Häkkinen et al. 2013; Moger and Peltola 2014; Iversen et al. 2015) and indicators (Malmivaara et al. 2015) 
for an international register-based health-care performance measurement and comparison, giving proposals 
concerning the data content of national registers in order to improve national- and international-level 
continuous monitoring and implement European-wide health-care benchmarking.  
The study is part of an effort to update and further develop the EuroHOPE research infrastructure, with 
the aim of evaluating the performance of health-care systems in terms of outcomes, quality, use of 
resources and costs. These include maintaining and updating the EuroHOPE protocols for selected 
diseases/conditions (acute myocardial infarction, stroke, hip fracture). The protocols include, e.g. 
inclusion/exclusion criteria, defining the cycle of care (when it starts, follow-up, etc.), comorbidities (used 
in risk-adjustment) and specifying the process, utilisation and cost and outcome measures. National, 
regional and hospital-level indicators have been calculated for Finland, Denmark, Hungary, Italy, Norway 
and Sweden (http://www.eurohope.info). In this pilot study, the databases have been extended to include 
primary health care and social services using data from the capital area of Finland (Helsinki and Espoo), 
Copenhagen, Oslo and Stockholm. 
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2 Aims 
Using linkable patient-level data on incident acute myocardial infarction (AMI), acute coronary 
syndrome (ACS), stroke and hip fracture patients, the present pilot study will: 
• Extend disease-based performance analysis to include new indicators that better describe patient care
pathways at different levels of care; 
• Describe and compare the performance of care given in the four metropolitan areas;
• Evaluate how additional data (primary and social services, better risk-adjustment and new outcome
measures) change the rankings of performance between the areas and discuss their usefulness for better 
understanding the reasons behind performance differences; 
• Describe the trends in performance between the metropolitan areas.
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3 Institutional settings 
The health care systems in the Nordic countries are generally regarded as being similar, but significant 
differences exist in the organisation of health care as well as in practical health policies between the Nordic 
countries (Lykens et al. 2016; Magnussen et al. 2009). The Nordic countries are subject to various levels of 
decentralisation. In Denmark, the health-care system is embedded in a decentralised administrative 
structure consisting of five regions and 98 municipalities. In Finland, the system is the most decentralised 
because 315 municipalities are responsible for arranging and taking financial responsibility for an entire 
range of health services, which also includes health centres that provide primary health-care services. In 
Sweden, the county councils are responsible for hospital and primary care, and there are relatively large 
variations in the organisation and remuneration schemes among them. The Norwegian model is the most 
centralised: primary care and long-term care services are organised and financed at the municipal level, 
while hospital services are organised and financed by health enterprises that are part of larger state-owned 
units called Regional Health Authorities. 
Regarding the patient pathways of the three disease groups considered in this study, important 
differences between the countries can be expected to be related to at least two issues: vertical integration of 
providing and financing health and social services and the arrangement of general practitioner (GP) 
services (Häkkinen and Johnsson 2009; Iversen et al. 2016; Olsen et al. 2016). The vertical integration of 
provider responsibilities is rather high in Finland, as the various municipalities are financially responsible 
for all health and social care. In Denmark, Sweden and Norway, vertical integration is lower, as the 
responsibility is divided between two tiers (regional authorities and municipalities). Denmark and Sweden 
have, however, had payment systems that may integrate the two tiers. Vertical integration has been lower in 
Norway. The Coordination Reform of 2012 may have changed this situation, though, as new payment 
systems between municipalities and hospitals have now been implemented.   
In Denmark and Norway, GPs are self-employed and operate on contract with the different regions 
(Denmark) or municipalities (Norway) as private practitioners (five per cent of Norway’s salaried GPs are 
primarily located in remote areas). In Sweden, the organisational schemes vary between public and private 
GPs. Most physicians working at public health centres are salaried employees, whereas most private GPs 
are self-employed in solo or group practices. Sweden is the only Nordic country to allow corporate 
ownership, which is a smaller share of the private GP sector. Most doctors are still employed by public 
providers; however, there is a trend towards more private practices, particularly in certain regions where 
about 50% of provision is private. This trend has been supported by national regulations since 2010 that 
encourage freedom of establishment for private providers, competition between primary care providers on 
equal terms and enhanced patient choice. In Finland, GPs working at health centres are also mainly salaried 
doctors, although they can either supplement their salary with a fee per consultation according to 
agreements made at the local level.
1
Next, we describe in more detail how health and social care have been organised in the four 
metropolitan areas that are the focus of the study. 
1
 In Finland, the GP services are also provided by private doctors and occupational health care is partly 
reimbursed by the Social Insurance Institution. However, these providers mainly offer services to children and 
the working-age population. Thus, the municipal health centers are the main providers of GP services for the 
patients considered in this study.    
3 Institutional settings 
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 3.1 Denmark/Copenhagen 
In Denmark, all public hospitals are owned and run by five regions. Primary health care (GPs and 
practising specialists) is financed by the regions as well. Home-based care, nursing home care and 
rehabilitation after discharge from a hospital are municipal responsibilities. Each of the regions and their 
municipalities coordinate the treatment of their patients. Patients diagnosed with specific chronic illnesses 
and patients discharged with an identified need for rehabilitation have a right to rehabilitation and health-
promotion services from the municipality. In addition, the municipality can initiate rehabilitation if it 
considers such rehabilitation appropriate. The allocation of home nursing and home help is based on an 
assessment of need, either by the municipality itself or by the hospital. Copenhagen is the largest 
municipality in Denmark, with almost 600,000 inhabitants. The municipality covers most of the capital, 
and hence, a very diverse population in terms of demographics and socio-economic status.  
Citizens of Copenhagen are also citizens of the capital region (total population 1.4 million), which is 
responsible for the financing of hospitals and primary health care. Like the rest of the country, hospital care 
is provided by regionally-owned hospitals, while primary health care is provided by private practices that 
negotiate their tariffs with the regions. There are no co-payments in either hospitals or primary health care. 
The municipal services are divided into health and social care. Municipal health services cover home 
nursing and rehabilitation/health promotion for all age groups and home help and nursing homes for people 
over 64. These services for younger citizens are considered social services. Generally, people younger than 
65 would only require such services if they are disabled. Home nursing is care provided by trained nurses 
or nurse assistants in the home of the patient. Home nursing is prescribed by the general practitioner or 
hospital, and the nursing and all equipment, etc., is financed by the municipality with no co-payments. 
Rehabilitation and health promotion usually take place in the health centres. The intensity and organisation 
of the rehabilitation varies. Citizens with a need for rehabilitation are offered either individual sessions or 
class training, depending on their needs and their circumstances. Home help is divided into personal care 
(e.g. bathing) and practical assistance. The municipality assesses the need of the citizens and then offers, 
e.g. 20 minutes per day or 1 hour per week of assistance. Citizens (or their relatives) can apply for a nursing
home residence. This application is then assessed by the municipality. There is a waiting list for nursing
homes, and a nursing home residence can be provided up to several months after completing an application
(Ministry of Health 2017).
3.2 Finland/Helsinki area 
In Finland, municipalities are responsible for arranging and financing health and social services. Many 
municipalities have merged their health and long-term service administration, including the budgeting of 
these services, in order to improve the coordination and integration of services. In Finland, most of the 
hospitals are owned by a federation of municipalities and are thus financed by the municipalities via 
reimbursement methods decided at the local level (Vuorenkoski et al. 2008). Although a Diagnoses Related 
Group (DRG) is used in most of the hospital districts, it is not centrally decided beforehand, and its main 
aim is not to motivate an increase in activity and efficient production of hospital services, but to equalise 
the municipal financing so that it is based on the accurate use of services.  
Since municipalities in Finland are responsible for financing all public health and long-term services, 
and even other services (basic education, social services, day care, etc.), they have motives for developing 
local-level actions to contain costs. The local interventions have usually been made at the municipal level, 
sometimes creating considerable differences in care pathways even between neighbour municipalities. For 
example, within the capital area of Helsinki, there was great variation between the municipalities in how 
rehabilitation and other activities following hospitalisation were organised (Mäkelä et al. 2007). In Finland 
it is widely accepted that the primary care provided for inactive people is underfunded (Vuorenkoski et al. 
2008), and many initiatives aiming to improve the quality and volume of primary health care have not 
succeeded thus far (Olsen et al. 2016). Improving the role of primary care is also the starting point for the 
current health and social care reform, which is under preparation in 2018. 
3 Institutional settings 
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This study includes two cities in the Helsinki area: Helsinki (pop 620,715 in 2014) and Espoo (pop 
265,543). The two cities provide primary health-care services and social-care services separately to their 
populations. In Finland, the municipalities can decide the co-payments up to a maximum decided by the 
government. In hospital care, there are co-payments for adults throughout the whole country, but some 
municipalities offer GP services provided by municipal health centres free of charge. Helsinki abolished the 
charges for GP services at the beginning of 2013, whereas in Espoo co-payments have been in use 
continuously. 
 In the Helsinki area, specialised care is provided by the Helsinki and Uusimaa hospital district. Most 
acute specialist care is produced by the Helsinki University Hospital, which used DRGs as the main 
reimbursement method. The hospital district of Helsinki and Uusimaa introduced a fine to reduce bed-
blocking in 2007 in order to increase the efficiency of the hospital. This practice was abolished in 
September 2009, but reintroduced in July 2011. The fee was €365 per day in 2011, €465 per day in 2012, 
and €600 per day in 2013 and 2014, i.e. much higher than the average cost per day in health centres, 
rehabilitation institutes and nursing.    
3.3 Norway/Oslo 
In Norway, all public hospitals are owned and operated by the four state-owned regional health 
authorities (RHAs). The RHAs also contract with non-profit and for-profit hospitals. Somatic care is 
financed by the central government using fixed DRG prices (50%) and risk-adjusted capitation (50%). 
Psychiatric care and care for addicts is financed by risk-adjusted capitation. Primary health care, social care 
and long-term care are financed by the municipalities. A specific fee-for-service from the central state 
covers parts of the GP’s revenues. The municipalities are financed by local taxes and grants from the 
central state. There are co-payments both in primary health care and hospital outpatient consultations, but 
not for inpatient stays. 
The capital of Norway, Oslo, has a population of approximately 675,000 inhabitants (2018) and is 
divided into 15 boroughs, which are delegated the responsibility for primary, social and long-term care. 
Four hospitals (Oslo University Hospital, Akershus University Hospital and the two non-profit hospitals 
Diakonhjemmet and Lovisenberg) are responsible for specialist care, each with a specific catchment area, 
but with close cooperation regarding tertiary care. 
The Coordination Reform represents a comprehensive policy package involving several measures to 
better integrate the two levels of services (MoHC 2009). Two new laws were implemented: the Norwegian 
Public Health Act and the Act of Municipal Health and Care Services, both of which aim to reinforce the 
municipalities’ responsibility for public health. The two most important financial measures of the 
Coordination Reform included (a) municipal co-financing of patients treated in the state-owned specialist 
health care services and (b) municipal financial responsibility for patients ready for discharge (Forskrift om 
medfinansiering av spesialisthelsetj. FOR-2011-06-29-695, 2012). Municipal financial responsibility for 
patients ready for discharge was enforced by the implementation of a fee to reduce patient overstays in 
hospitals, so-called bed-blocking (Gaughan et al. 2015). The fee was paid by the municipality to the 
hospitals for patients declared ready for discharge who were in need of services from the municipalities, but 
were unable to leave the hospital because of a lack of municipal services. The hospitals had to notify the 
municipalities in advance about patients who needed municipal services. The fee was set at approximately 
€535 per day (4,000 NOK) in 2012 and paid from day one after the patient was declared ready for 
discharge (1 €=7.47 NOK, which was the exchange rate in 2012). Also included in the reform package was 
an economic stimulus for the municipalities to build up services to tackle the increased care burden. Initial 
analyses indicate that the fee has reduced the length of stay in hospitals for the relevant patients (Melberg 
and Hagen 2016).  
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3.4 Sweden/Stockholm 
In Sweden, the 21 county councils are responsible for financing and arranging health care, whereas the 
290 municipalities are in charge of institutional and home care for the elderly. The county councils levy 
their own taxes for such care, which covers 70% of their costs while 20% is paid through central 
government grants. The capital of Sweden, Stockholm, is part of the greater Stockholm county council 
(total population 2.2 million in 2014). 
Hospital service is mainly provided by county council-owned hospitals on three levels: university, 
central and county hospitals.  Each county decides on the reimbursement system, and there has been a 
decline in the share of hospitals that are reimbursed with the DRG systems. In 2015, less than half of them 
were reimbursed via the DRG system, while the others were reimbursed by budgets or block grants. There 
are co-payments both in hospitals and primary health care 
In Stockholm, there are seven acute hospitals, wherein the two university hospitals have been merged 
into a single organisation. There is one for-profit hospital and three hospitals under public corporate 
ownership by the county council in Stockholm. During the study period, the Stockholm county council 
applied a system where the variable part based on DRGs comprised approximately 75–80% of the total 
reimbursement and a fixed payment of approximately 10%. The remaining part was also variable, but based 
on quality indicators and a patient choice model for specific procedures. 
There is a patient co-payment for outpatient consultations, and a small fee charged per day for inpatient 
stays. Both payments are combined with a maximum ceiling for patient fees and applies to all county 
councils.  
The primary health-care sector has traditionally been under public provision based on catchment areas. 
However, since 2010 the new legislation has stipulated a choice of primary care provider for the population 
and freedom of establishment for providers accredited by the local county councils. Patients can register 
with any public or private providers, which are reimbursed by the county councils on equal terms. In 
Stockholm, the share of private GPs is approximately 60% of the market, and the reimbursements 
constituted a mix of capitation (40%) and payment per visit (60%) during the study period. 
In Sweden, nursing homes and home care for older people and patients with chronic conditions are the 
responsibility of the 290 municipalities. However, the medical responsibility rests with the county councils. 
The so-called 1992 ÄDEL Reform shifted the responsibility for care for older people from the county 
councils to the municipalities. Collaboration with primary care services is needed, as municipalities are not 
allowed to employ physicians, only nurses and other personnel. For this purpose, nursing homes generally 
have agreements with health centres. In relation to hospital care, discharge planning for the elderly in 
collaboration with the municipality and primary care are mandatory. The municipality is required by law to 
organise an adequate capacity of nursing home services. In Stockholm, the system and collaboration 
between the county council and the 26 municipalities is somewhat different, as the county council is in 
charge of home visits concerning health services performed by nurses. 
Problems of so-called bed-blockers have been discussed for decades, with municipalities having to pay 
a fine for patients declared ready to be discharged from a hospital since the ÄDEL Reform. Regulation has 
been strengthened several times since then, and studies suggest that the problem of so-called bed-blockers 
has been reduced due to these policies. However, after each change the significant problems related to bed-
blockers have reached a new plateau and are still being debated with respect to the elderly and improving 
the efficiency of hospitals. 
3 Institutional settings
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4 Data and Methods 
4.1 Data 
This study analysed annual cohorts of AMI, ACS, ischemic stroke and operated hip fracture patients 
from Copenhagen (CPH), the Helsinki metropolitan area (municipalities of Helsinki and Espoo, HEL), 
Stockholm (STO) county and Oslo (OSL). The total numbers of population (2014) were as follows: 
- Copenhagen 569,557, of whom those over 69 years of age is 6.6 %
- Helsinki area 886,260, of whom those over 69 years of age is 9.9 %
- Oslo 641,550, of whom those over 69 years of age is 8.1 %
- Stockholm 2,198,044, of whom those over 70 years of age is 10.6 %.
The construction of data was based on a common protocol using routinely collected national registers 
and statistics on hospital discharges, use of prescribed medication and causes of death (Häkkinen et al. 
2013; Moger and Peltola 2014). We defined episode of care as referring to the entire treatment pattern from 
the beginning (e.g. time of diagnosis) of the disease to the end of the treatment across organisational 
boundaries to face the health problem at hand within a specific time frame. Thus, the protocols for an 
episode include the definitions of start and finish dates (follow-up time) as well as inclusion and exclusion 
criteria, which are used when constructing a comparison data set for a specific disease group. 
Episodes of AMI, ACS, stroke and hip fracture start with an acute phase in the hospital, usually 
occurring immediately after the event. For stroke, we included only cerebral infarction (ischemic stroke) 
patients, and for hip fracture only operated patients. The beginning of the episode (index day) was defined 
as the first hospital day of a hospital admission with a specific primary diagnosis (AMI ICD-10 codes I21–
I22; ACS ICD-10 codes I20.0, I21–I22; ischemic stroke ICD-10 code I63; hip fracture ICD-10 codes 
S72.0–S72.2), using  two exclusions. First, we excluded all patients who had a hospital admission related to 
the condition in question during the 365 days prior to the index day. Second, we excluded foreigners and 
patients with an incomplete personal identity number. In addition, for hip fracture we excluded patients 
younger than 50 years.  
For this pilot study, we extended the approach to primary health and long-term care services by 
collecting data on these services from local municipal registers. We constructed a comparative database 
that allows for performance analysis, research and use of indicators at the local (capital area) level (Figure 
1). Our approach requires patient-level data covering the whole population in the selected areas and the 
possibility to deterministically link individuals’ records in the different national registers used. 
The construction of patient cohorts is described in the protocols (EuroHOPE 2016a, 2016b, 2016c). 
Each partner was individually responsible for producing its own local EuroHOPE comparison data, with 
the principles stated in the disease-specific study protocols. 
For this study, we created new variables that also cover the use of primary and social services. To track 
the patients’ movements along the care pathway, we constructed a new four-digit state variable that 
describes the services the patient received for each day 365 days before and 365 days after the index day 
(Sund and Häkkinen 2016). The index day is also included in the state variable. The first digit specifies 
whether the patient was at home with no services, whether services were received and whether the patient 
was dead or alive. The second digit specifies a hierarchy of services, with the use of university hospitals at 
the top level and different types of hospital and long-term care services with home help at the lowest level. 
The third digit indicates whether or not the hospital stay had the specific condition (AMI/ACS, ischemic 
stroke or hip fracture) as the main diagnosis, and the fourth digit indicates a hierarchy of outpatient services 
with a hospital outpatient visit at the top and GP visits at the bottom. 
4 Data and Methods 
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Figure 1. Description of the creation of the data. 
In addition, we collected new variables describing the total number of various visits at 90 and 365  days 
before and after the index day. The visit categories were as follows:  
(a) Day surgery
b) Outpatient visits to hospital
c) Outpatient physician consultation with private or public specialist outside hospital
d) GP visit
e) Consultations with local emergency centre patients
f) Home visits by doctor
g) Visits to a nurse in primary care
h) Home care (help) visits.
4.2 Performance measures 
A simple descriptive analysis of outcomes can be made using this new state variable. It describes each 
365 day period before and after the index day to which the exclusive service/setting groups/patients belong. 
From the new state variable, we calculated descriptive statistics on service use and outcomes, such as the 
share of patients permanently discharged to home within 90 days and still alive at the end of the period. 
Here, permanently means that a patient must be continuously at home for at least two weeks after 
discharge, i.e. without being transferred to any inpatient care facility within that period. We calculated the 
measures separately for overall discharges to home and for discharge to home without any home help 
services within the two-week period.  
Outcomes were also measured by mortality (30-day, 90-day, and one-year) and by the share of patients 
institutionalised within 90 and 365 days. Institutionalisation was defined as the patient being in inpatient 
care (including, e.g. a nursing home) all days during the follow-up time.  
4 Data and Methods 
 
THL — Discussion paper 22/2018 16 
Performance comparison of patient 
pathways in Nordic capital areas 
 
Service utilisation was measured by number of visits (GP, other doctor visits
2
 and home help services) 
and bed days within one year after the index day. Length of stay (LOS) was defined in three ways: for acute 
hospital episode (including transfers between acute hospitals), acute care and rehabilitation episode, and the 
first institutional episode that also includes, in addition to the acute hospital care and rehabilitation, long-
term care institutions like nursing homes during the first 90 days after the index day if a patient is 
transferred to such institutions immediately after acute care and rehabilitation admissions.   
In addition to using LOS as a measure of resource utilisation, costs were measured by using the Finnish 
standard cost of specific cost items (Kapiainen et al. 2014), which were deflated to 2014 price levels. In 
acute hospital care, costing was done by regressing the cost at the individual level using data from patients 
treated at Helsinki University Hospital against resource items (e.g. hospital days, use of a specific 
procedure, type of fracture). Patient-level costs were then derived using the coefficients of the regression 
models. The descriptions of the costing methods are described in Appendix 1. Data on some cost items (e.g. 
prescribed drugs, visits to a nurse in primary care and private health care services) was only available from 
the Helsinki area. Their share of the total cost was estimated to be from 2 to 5%. 
 
4.3 Missing data 
We had full data covering the cohorts from the years 2009–2014 only from the Helsinki area. For 
Copenhagen, we had full data only for the 2014 cohort. For Stockholm, the data covered the cohorts for 
2009–2014, but did not include information on institutional long-term care or home help services (except 
home visits by nurses and doctors). Data on prescribed medicines from Stockholm was only available since 
July 2010.    
For Oslo, it was not possible to obtain data on the prescribed medicines. Furthermore, we could only 
follow patients to the end of the year 2014. Thus, we could not calculate the indicators requiring a 365-day 
follow-up for patients treated in 2014. For the variables based on a shorter follow-up, we excluded patients 
with an index day after mid-September of 2014.   
 
Table 1 describes the main performance indicators and their availability by the metropolitan area. 
 
4.4 Risk-adjustment 
Patient-associated factors must be accounted for when comparing the areas. We have endeavoured to 
ensure meaningful comparisons using three steps. First, we defined the disease groups so that they are as 
comparable and homogeneous as possible. Second, we gathered information on risk factors from the 
patients' medical history and patient use of services before the onset of the disease (based on the state 
variable). Third, we applied statistical models to adjust the indicators and calculated their 95% confidence 
intervals. 
Age, sex and type of disease are the most commonly used variables in risk-adjustment. Here, we used 
two additional sets of variables: the number of days a patient had been in different service settings before 
the index day and comorbidities. Using the state variable, we calculated the number of days the patient had 
been in acute hospital care, other institutional care and home help during the 90 days before the index day.  
Comorbidities were assessed using patients’ medical records of the previous year from two data 
sources: i) based on the primary or secondary diagnoses recorded during hospital admissions within 365 
days prior to the index admission, and ii) based on purchase of medications that can be linked to particular 
diagnoses (Moger and Peltola 2014). We calculated the comorbidity for 12–13 diseases (Table 2).  
 
 
                                                        
 
 
2
 Include visits to specialist, emergency and outpatient departments of hospitals 
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Table 1. Performance indicators and their availability in the capital areas 
Performance indicator  Data available 
30-day mortality CPH 2014, HEL 2009-2014, OSL 2009-2014, 
STO 2009-2014 
90-day mortality CPH 2014, HEL 2009-2014, OSL 2009-2014, 
STO 2009-2014 
One-year mortality CPH 2014, HEL 2009-2014, OSL 2009-2013, 
STO 2009-2014 
Share of patients discharged home (total) within 90 days CPH 2014, HEL 2009-2014, OSL 2009-2014 
Share of patients discharged home (without help) within 
90 days 
CPH 2014, HEL 2009-2014, OSL 2009-2014,  
Share of patients institutionalised (90 days) CPH 2014, HEL 2009-2014, OSL 2009-2014 
Share of patients institutionalised (one year) CPH 2014, HEL 2009-2014, OSL 2009-2014  
Length of first acute hospital admission CPH 2014, HEL 2009-2014, OSL 2009-2014, 
STO 2009-2014 
Length of first acute hospital and inpatient rehabilitation 
admissions 
CPH 2014, HEL 2009-2014, OSL 2009-2014, 
STO 2009-2014 
Length of first institutional episode CPH 2014, HEL 2009-2014, OSL 2009-2014 
Number of all inpatient days (including long-term care), 
one year 
CPH 2014, HEL 2009-2014, OSL 2009-2013 
Number of GP doctor visits (one year) CPH 2014, HEL 2009-2014, OSL 2009-2013, 
STO 2009-2014 
Number of other doctor visits (one year) CPH 2014, HEL 2009-2014, OSL 2009-2013. 
STO 2009-2014 
All home help visits (one year) CPH 2014, HEL 2009-2014, OSL 2009-2013  
Cost of first acute hospital episode CPH 2014, HEL 2009-2014, OSL 2009-2014, 
STO 2009-2014 
Cost of first acute hospital and inpatient rehabilitation 
episode 
CPH 2014, HEL 2009-2014, OSL 2009-2014, 
STO 2009-2014 
Cost of first institutional episode CPH 2014, HEL 2009-2014, OSL 2009-2014  
One-year cost CPH 2014, HEL 2009-2014, OSL 2009-2013  
Likewise, the availability of data for various performance measures and risk-adjustment variables varied 
between the capital areas. Thus, for each performance indicator we performed risk-adjustment with four 
different sets of confounders, as indicated in Table 3. 
For all performance indicators, a modelling strategy for risk-adjustment was adopted: logistic regression 
for dichotomous responses (e.g. mortality), generalised linear modelling for continuous variables (e.g. costs 
gamma distribution with logit-link) and negative binomial modelling for discrete variables (e.g. length of 
stay). Ideally, the individual-level data from all participating areas would be pooled before estimating the 
risk-adjustment models. However, at this stage we did not have permission from all the partners to pool the 
individual-level data. Thus, we applied a standard approach for indirect standardisation in which the 
parameter estimates for the confounding factors were first estimated for each performance indicator using 
the data from the Helsinki area from the years 2009–2014. Then, the coefficients of each model were made 
available to all partners, who then calculated individual-level predicted values for the indicators. The 
predicted values were then summed up for an area by year. The ratio of the observed value and the 
expected value of the dependent variable in the comparable unit was multiplied by the average value of the 
indicator in the Helsinki area data to constitute the risk-adjusted indicator. Thus the adjusted estimates 
correspond to assuming effects of all risk adjusters are the same as in the Helsinki area. The calculation of 
the risk-adjusted indicators using data for all years (Tables 4-8) was based on models that also included 
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year dummies. It should be noted that confidence intervals reflect the numbers of patients included in the 
sample. Thus they are very wide for Copenhagen and narrow for Stockholm.  The mean values of the 
variables included in risk-adjustment for the capital areas and performance indicators are reported in 
Appendix Tables 1–5. 
 The age- and sex-standardised incidence figures for the diseases were carried out via indirect 
standardisation using the age and sex reference values for the Helsinki area from the years 2009–2014 as 
the basic population. 
 
 
Table 2. Comorbid diseases and their operationalisation from the study data 
 
Comorbidity ICD-10 ATC-code 
Hypertension I10*-
I15* 
C03*, C07* (with neither coronary 
artery disease nor atrial fibrillation indicates 
hypertension), C08*, C09* 
Coronary artery 
disease 
I20*-
I25* 
N/A 
Atrial fibrillation I48* N/A 
Cardiac insufficiency I50* N/A 
Diabetes mellitus E10*-
E14* 
A10A*, A10B* 
Atherosclerosis I70* N/A 
Cancer C00*-
C99**, 
D00*-D09* 
L01* (except L01BA01) 
COPD and asthma J44*-
J46* 
R03* 
Dementia F00*-
F03*, G30* 
N06D* 
Depression F32*-
F34* 
N06A* 
Parkinson’s disease G20* N04B* 
Mental disorders F20*-
F31* 
N05A* (except N05AB01 and 
N05AB04), and no dementia 
Stroke (used for AMI 
/ACS and hip fracture)  
I60*, 
I61*, I63*, 
I64*, G45* 
 
 
N/A 
N/A = not available   
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Table 3. Risk-adjustment models 
Model Availability 
M1: age, sex, type of disease (specific disease, 
e.g. type of AMI, ACS and type of hip fracture).
CPH 2014, HEL 2009-2014, OSL 2009-
2013/2014, STO 2009-2014  
M2: M1 + number of days in different care 
arrangements 90 days before index day (acute 
hospital days, other institutional days, days at 
home with help).  
CPH 2014, HEL 2009-2014, OSL 2009-
2013/2014   
M3: M1 + comorbidity using data from previous 
year, use of hospital care and prescribed 
medicine.  
CPH 2014, HEL 2009-2014, STO July 
2011-2014 
M4: M1 + additional variables of M2 and M3. CPH 2014, HEL 2009-2014 
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5 Acute myocardial infarction and acute 
coronary syndrome 
5.1 Patient structure 
The number of incident AMI and ACS patients varied considerably between the areas. The age- and 
sex-standardised number of AMI patients per 10 000 people in the Helsinki area was 7.0 (varying over the 
years from 6.5 to 8.2), in Copenhagen 14.3 (2014) and in Oslo 19.9 (17.6–22.7) and in Stockholm 13.9 
(11.9–15.1). Corresponding figures for ACS were 8.0 (7.4–9.3) in the Helsinki area, 17.5 in Copenhagen, 
23.7 (21.3–27.1) in Oslo and 15.4 (13.8–17.2) in Stockholm. The main reason for the low incidence in the 
Helsinki area was that the sample included only patients treated at Helsinki University Hospital, which is 
the only acute care hospital in the area. However, AMI/ACS patients are also treated in health centres 
throughout the area. These patients were excluded from the data since the units also treat long-term care 
patients and the index day cannot be reliably defined for them. 
The differences in the selection of patients were also reflected in the age structure of the samples. The 
patients were older in Oslo and Stockholm compared to the Helsinki area and Copenhagen (Appendix, 
Tables 1 and 2). The share of STEMI (ST-Elevation Myocardial Infarction) patients was highest in the 
Helsinki area. During the 90-day period before the index day, the patients in Oslo had more inpatient days 
in other institutions (rehabilitation and long-term care institutions) than in the Helsinki area and 
Copenhagen. In Oslo and Copenhagen, the patients received more home help compared to Helsinki before 
the index day. Thus, risk- adjustment is necessary for meaningful comparison.  
5.2 Mortality 
Unadjusted mortality figures were lower in Copenhagen and the Helsinki area compared to the other 
areas. When mortality was compared separately by age for patients over and below 75 years of age, the 
rates were still somewhat lower in the Helsinki area and Copenhagen (Figure 2). Using model 1 for risk 
adjustment, mortality (30-day, 90-day and one-year) figures were highest in Stockholm, and with most of 
them, the difference was significant compared to Copenhagen based on non-cutting confidence intervals 
(Tables 4 and 5). Most of the risk-adjusted figures were not significantly different between Copenhagen, 
the Helsinki area and Oslo. When risk adjustment was made using model 2, 30-day mortality figures were 
lower in Copenhagen and Oslo than in the Helsinki area. However, when comorbidities were also used as 
additional risk factors (model 4) the difference between the Helsinki area and Copenhagen was no longer 
significant. Ninety-day mortality was also significantly higher in the Helsinki area compared to 
Copenhagen when risk- adjustment was performed using model 4. In Stockholm and Oslo, 30-day and one-
year mortality were quite stable during the study period, whereas in the Helsinki area a clear decrease 
occurred between the years 2009 and 2011 (Figure 3). 
5.3 Use and cost of services 
The use and structure of out-patient doctor services varied between the areas. The total number of GP 
visits per patient during the one-year follow-up was clearly higher in Oslo (8 visits) and Copenhagen (6–7 
visits) than in Stockholm (4–5 visits) and the Helsinki area (2–3 visits). The risk-adjusted figures did not 
change the ranking between the areas (Tables 4 and 5). Less use of GP services was compensated for by 
relatively more use of other doctor visits in Stockholm and the Helsinki area compared to Oslo. But in 
Copenhagen the use of other doctor visits was clearly higher than in other areas because of a heavy use of 
hospital outpatient services. The most substantial change during the study period was the increase in the 
number of GP visits in Oslo (Figure 4). 
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Figure 3. Risk-adjusted (model 1) 30-day and one-year mortality, 2009–2014, AMI patients. 
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Table 4. Risk-adjusted performance indicators, AMI patients
#
 
Value min95 max95 Value min95 max95 Value min95 max95 Value min95 max95
30 -day mortality
Model 1 0.049       0.031       0.068   0.068 0.060 0.076 0.064 0.059 0.068 0.073 0.070 0.077
Model 2 0.042       0.027       0.058   0.068 0.060 0.076 0.053 0.049 0.057
Model 3 0.051       0.032       0.070   0.068 0.060 0.076 0.080 0.075 0.085
Model 4 0.048       0.030       0.066   0.068 0.060 0.076
90-day mortality
Model 1 0.057       0.039       0.076   0.083 0.074 0.091 0.087 0.081 0.092 0.095 0.091 0.098
Model 2 0.046       0.032       0.061   0.083 0.075 0.091 0.072 0.068 0.077
Model 3 0.059       0.040       0.078   0.083 0.075 0.091 0.102 0.097 0.107
Model 4 0.052       0.035       0.069   0.083 0.075 0.091
One-year mortality
Model 1 0.109       0.082       0.135   0.122 0.112 0.132 0.138 0.131 0.144 0.142 0.138 0.146
Model 2 0.091       0.070       0.113   0.122 0.112 0.132 0.121 0.115 0.126
Model 3 0.112       0.086       0.139   0.122 0.112 0.132 0.160 0.173 0.151
Model 4 0.104       0.080       0.129   0.122 0.112 0.131
Length of  first acute hospital admission
Model 1 9.0           8.2           9.8        8.4       8.2       8.7       7.1       7.0       7.3       6.2       6.2       6.3       
Model 2 8.5           7.8           9.2        8.4       8.2       8.7       7.3       7.2       7.5       
Model 3 9.1           8.3           9.9        8.4       8.2       8.7       6.0       5.9       6.1       
Model 4 8.7           7.9           9.4        8.4       8.2       8.7       
Length of  first acute hospital and  rehabiltation  admissions
Model 1 10.4         9.4           11.4     10.2    11.0    10.5    11.2    10.8    11.6    7.5       7.3       7.6       
Model 2 8.6           7.8           9.5        10.1    10.9    10.6    10.1    9.7       10.5    
Model 3 10.3         9.3           11.3     10.2    11.0    10.5    7.3       7.2       7.5       
Model 4 8.8           7.9           9.6        10.1    10.9    11.8    
Length of first institutional episode
Model 1 12.6         11.1         14.1     11.8    11.3    12.3    13.8    13.3    14.3    
Model 2 10.3         9.2           11.4     11.7    11.2    12.2    10.5    10.2    10.8    
Model 3 12.3         10.9         13.8     11.8    11.3    12.3    
Model 4 10.3         9.2           11.5     11.7    11.2    12.1    
Number of days in acute hospital care, one year
Model 1 13.0         11.8         14.2     11.8    11.3    12.2    9.6       9.4       9.9       10.6    10.5    10.8    
Model 2 11.8         10.7         12.8     11.6    11.1    12.1    9.9       9.6       10.2    
Model 3 13.1         12.0         14.3     11.8    11.3    12.2    10.1    9.9       10.3    
Model 4 12.4         11.3         13.5     11.7    11.2    12.1    
Number of inpatient  days, one year
Model 1 24.0         19.7         28.2     23.6    22.0    25.2    29.0    27.4    30.5    
Model 2 12.5         17.2         21.6     22.1    20.5    23.7    15.1    14.4    15.8    
Model 3 21.6         17.7         25.5     23.1    21.6    24.7    
Model 4 15.5         13.0         17.9     22.2    20.7    23.8    
Number of GP visits ,one year
Model 1 5.8           5.3           6.3        2.6       2.5       2.7       8.1       7.8       8.3       4.5       4.4       4.6       
Model 2 6.2           5.7           6.7        2.6       2.5       2.7       8.6       8.4       8.9       
Model 3 5.9           5.4           6.4        2.6       2.5       2.7       4.5       4.3       4.6       
Model 4 6.4           5.9           7.0        2.6       2.5       2.7       
Number of other doctor  visits,one year 
Model 1 13.0         11.9         14.1     6.7       6.2       7.1       1.5       1.4       1.6       6.8       6.7       7.0       
Model 2 12.3         11.2         13.4     6.6       6.1       7.0       1.5       1.4       1.6       
Model 3 13.2         12.1         14.4     6.7       6.2       7.1       6.5       6.2       6.7       
Model 4 13.2         12.0         14.3     6.7       6.2       7.1       
Number of home help  visits, one year
Model 1 42.8         29.2         56.3     21.0    18.1    23.8    39.1    36.2    42.0    
Model 2 14.2         10.1         18.3     21.0    18.5    23.4    16.6    15.4    17.8    
Model 3 40.9         27.8         54.0     21.0    18.2    23.8    
Model 4 14.4         10.2         18.5     21.0    18.5    23.4    
Cost of  first  acute hospital  episode
Model 1 9265 8497 10033 9861 9573 10149 7289 7135 7443 6747 6657 6837
Model 2 8977 8240 9714 9848 9563 10134 7628 7465 7791
Model 3 9359 8585 10134 9861 9574 10147 6455 6343 6567
Model 4 9059 8318 9800 9848 9563 10133
Cost of  first  acute  and rehabilitation hospital  episode
Model 1 9574 8767 10380 10353 10049 10656 8280 8089 8470 7128 7033 7224
Model 2 8998 8252 9745 10329 10027 10630 8397 8201 8592
Model 3 9637 8828 10446 10350 10049 10652 6758 6640 6875
Model 4 9066 8316 9815 10326 10025 10627
Cost of  first institutional  episode
Model 1 9961 9121 10800 10592 10281 10902 8902 8699 9104
Model 2 9326 8560 10092 9981 10262 10877 8618 8431 8805
Model 3 9981 9141 10821 10588 10279 10897
Model 4 9389 8620 10157 10588 10279 10897
One-year cost
Model 1 24731 22781 26682 19563 18883 20243 20063 19437 20688
Model 2 18803 17375 20230 19207 18499 19914 15196 14760 15632
Model 3 24422 22489 26356 19505 18846 20165
Model 4 19863 18366 21361 19269 18602 19937
# Risk adjustment variables  includes also year indicators  
Copenhagen 2014                                                        
(n=622) 
Helsinki area 2009-2014             
(n=3604)
Oslo  2009-2013/2014                              
(n=5491-6209)
Stockholm 2009/2011-2014               
(n=9978-17776)
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Table 5. Risk-adjusted performance indicators, ACS patients
# 
Value min95 max95 Value min95 max95 Value min95 max95 Value min95 max95
30 -day mortality
Model 1 0.047 0.030 0.065 0.062 0.055 0.069 0.056 0.052 0.060 0.067 0.064 0.070
Model 2 0.039 0.025 0.054 0.062 0.055 0.069 0.046 0.043 0.050
Model 3 0.048 0.030 0.066 0.062 0.055 0.069 0.071 0.067 0.076
Model 4 0.044 0.028 0.061 0.062 0.055 0.069
90-day mortality*
Model 1 0.054 0.037 0.071 0.077 0.069 0.084 0.078 0.073 0.083 0.087 0.084 0.090
Model 2 0.043 0.029 0.056 0.077 0.069 0.084 0.064 0.060 0.068
Model 3 0.055 0.037 0.072 0.077 0.069 0.084 0.091 0.086 0.096
Model 4 0.048 0.033 0.063 0.077 0.069 0.084
One-year mortality
Model 1 0.109 0.084 0.134 0.113 0.104 0.122 0.126 0.120 0.132 0.132 0.128 0.135
Model 2 0.087 0.068 0.107 0.113 0.104 0.122 0.108 0.103 0.113
Model 3 0.110 0.086 0.135 0.113 0.105 0.122 0.138 0.133 0.143
Model 4 0.100 0.078 0.122 0.113 0.105 0.122
Length of first acute hospital episode
Model 1 9.8 9.1 10.4 8.2 8.0 8.5 6.7 6.5 6.8 6.2 6.2 6.3
Model 2 9.2 8.6 9.9 8.2 8.0 8.4 6.8 6.7 7.0
Model 3 9.8 9.1 10.5 8.2 8.0 8.5 6.0 5.9 6.1
Model 4 9.4 8.7 10.0 8.2 8.0 8.5
Length of  first acute hospital and  rehabilitation episode
Model 1 11.3 10.4 12.2 10.2 9.8 10.6 11.2 10.8 11.6 7.4 7.6 7.6
Model 2 9.4 8.6 10.1 10.1 9.7 10.5 10.1 9.7 10.5
Model 3 11.2 10.3 12.1 10.2 9.8 10.6 7.3 7.2 7.4
Model 4 9.5 8.7 10.2 10.1 9.7 10.5
Length of first institutional episode
Model 1 13.7 12.3 15.1 11.4 10.9 11.8 13.8 13.3 14.3
Model 2 10.8 9.8 11.7 11.2 10.8 11.6 10.5 10.2 10.8
Model 3 13.3 11.9 14.6 11.3 10.9 11.8
Model 4 10.8 9.9 11.8 11.2 10.7 11.6
Number of days in acute hospital care, one year
Model 1 14.3 13.2 15.4 11.6 11.2 12.0 9.0 8.8 9.2 10.5 10.4 10.7
Model 2 13.0 12.0 14.0 11.4 10.9 11.9 9.2 9.0 9.5
Model 3 14.3 13.2 15.4 11.6 11.2 12.0 10.0 9.8 10.2
Model 4 13.6 12.6 14.6 11.5 11.1 11.9
Number of inpatient  days, one year
Model 1 26.0 21.8 30.1 22.9 21.4 24.4 27.1 25.7 28.4
Model 2 15.2 13.1 17.3 21.4 19.9 23.0 14.1 13.5 14.7
Model 3 23.2 19.4 27.0 22.4 21.0 23.9
Model 4 15.9 13.6 18.2 21.5 20.0 23.0
Number of GP visits ,one year
Model 1 6.7 6.2 7.1 2.7 2.6 2.8 8.5 8.2 8.7 4.6 4.5 4.7
Model 2 7.0 6.5 7.5 2.7 2.6 2.8 8.5 8.2 8.7
Model 3 6.6 6.2 7.1 2.7 2.6 2.8 4.6 4.4 4.7
Model 4 7.2 6.7 7.7 2.7 2.6 2.8
Number of other doctor  visits,one year 
Model 1 15.3 14.2 16.5 6.6 6.2 7.0 1.5 1.4 1.6 6.9 6.7 7.1
Model 2 15.0 13.8 16.1 6.5 6.1 6.9 1.6 1.5 1.7
Model 3 15.2 14.1 16.4 6.6 6.2 7.0 6.5 6.3 6.7
Model 4 15.6 14.3 16.8 6.6 6.2 7.0
Number of home help  visits, one year
Model 1 46.7 33.2 60.2 19.8 17.2 22.3 37.1 34.4 39.8
Model 2 14.0 10.4 17.7 19.8 17.6 22.0 15.8 14.6 16.9
Model 3 43.0 30.5 55.5 19.8 17.3 22.3
Model 4 14.1 10.5 17.8 19.8 17.6 22.0
Cost of  first  acute hospital  episode
Model 1 10765 10066 11463 9717 9436 9998 6736 6601 6872 6909 6820 6998
Model 2 10425 9750 11101 9702 9425 9980 7048 6904 7191
Model 3 10853 10151 11556 9717 9437 9996 6480 6372 6587
Model 4 10506 9828 11184 9701 9424 9977
Cost of  first  acute  and rehabilitation hospital  episode
Model 1 11128 10395 11860 10162 9869 10456 7220 7051 7389 7194 7102 7287
Model 2 10440 9757 11123 10133 9842 10424 7282 7113 7451
Model 3 11174 10441 11907 10160 9868 10452 6784 6671 6897
Model 4 10493 9810 11176 10128 9838 10419
Cost of first institutioina l  episode
Model 1 11583 10818 12347 10398 10098 10698 7638 7470 7807
Model 2 10754 10057 11450 10370 10074 10666 7744 7572 7916
Model 3 11577 10813 12341 10394 10096 10693
Model 4 10805 10108 11503 10363 10068 10658
One-year cost
Model 1 27813 26006 29620 18978 18358 19599 18530 17978 19082
Model 2 20899 19520 22277 18599 17945 19254 14124 13741 14507
Model 3 27121 25335 28908 18919 18317 19522
Model 4 21902 20474 23331 18679 18070 19288
# Risk adjustment variables  includes also year indicators  
Stockholm 2009/2011-
2014 (n=20366)
Copenhagen 2014 
(n=741)
Helsinki area   2009-
2014 (n=4129)
Oslo 2009-2012/2014 
(n=6548/7457)
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The unadjusted number of home help visits during the one-year follow-up was clearly higher in Oslo 
and Copenhagen compared to the Helsinki area. However, the risk-adjusted figures were dependent on the 
variables used for risk-adjustment. Age- and sex-based risk adjustment (model 1) decreased the difference 
in the number of visits between Oslo and Helsinki from 36–41 visits to 17–18 visits, but when the use of 
various services (including home help) during the 90-day period before the index day were also adjusted 
for (model 2), the number of home help visits was smaller in Oslo and Copenhagen (also model 4) 
compared to the Helsinki area. The two adjustment models even gave a somewhat different picture of the 
trends in home help visits in Oslo (Figure 5). 
The length of stay during the first acute hospital episode in the Helsinki area and Copenhagen was 
several days longer than in Oslo and Stockholm. Copenhagen was the only area where ACS patients 
remained in acute care longer than AMI patients. When rehabilitation admissions were also taken into 
account, the difference between the Helsinki area/Copenhagen and Oslo decreased (Tables 4 and 5). The 
length of stay during the first acute episode was, in 2009, at about the same level in the Helsinki area as in 
Oslo, but afterwards the measure increased in the Helsinki area until the year 2012, whereas in Oslo the 
measure showed a decreasing trend (Figure 6). In Stockholm, both the length of stay during the first acute 
episode and the first episode, including rehabilitation, were lowest throughout the whole study period.  
When hospital days also included long-term inpatient care (e.g. nursing homes), the results varied 
according to the risk-adjustment method. The unadjusted number of all inpatient days both during the first 
institutional episode and one-year follow-up were higher in Oslo than in Helsinki and Copenhagen. Risk- 
adjustment using model 1 equalised the difference between the areas, whereas using risk-adjustment model 
2 gave a higher number of days in the Helsinki area compared to Oslo and Copenhagen.  
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Figure 4. Risk-adjusted (model 1) number of visits to a doctor during one year after AMI. 
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Unadjusted cost figures during the first institutional episode were higher in the Helsinki area than in 
Oslo Copenhagen for AMI patients. Among ACS patients, these cost figures were about the same in 
Copenhagen as in the Helsinki area. However, the unadjusted and adjusted (model 1) one-year total costs 
were highest in Copenhagen, reflecting a greater use of acute care and outpatient hospital services. Again, 
especially the one-year total cost estimates varied according to the risk-adjustment method used. When 
model 1 was used for risk-adjustment, the one-year total costs in 2009 were higher in Oslo compared to 
Helsinki, but afterwards they increased in the Helsinki area and decreased in Oslo (Figure 7). This increase 
in Helsinki seems to be related to an increase in the use of acute hospital care during the first hospital 
episode. 
10
20
30
40
50
2009 2010 2011 2012 2013 2014
Year
Helsinki area, model 1 Helsinki area, model 2
Oslo, model 1 Oslo, model 2
Copenhagen, model 1 Copenhagen, model 2
Figure 5.  Number of home help visits (one year) using two risk- adjustment models, AMI patients. 
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Figure 6. Risk-adjusted (model 1) length of stay during first acute hospital episode with and without 
rehabilitation, AMI patients. 
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Figure 7. Risk-adjusted (model 1) cost during the first hospital episode and for one year, AMI 
patients.  
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6 Ischemic stroke 
6.1 Patient structure 
The number of incident ischemic stroke patients varied between the areas considerably less than the 
number of AMI and ACS patients. The age- and sex-standardised number of ischemic patients per 10 000 
people was in the Helsinki area 10.4 (varying over the years between 9.2 and 11.3), in Stockholm 15.6 
(13.7-–16.7), in Copenhagen 9.0 (2014) and in Oslo 14.0 (13.2–14.6). As for AMI patients, the patients 
were older in Oslo and Stockholm compared to the Helsinki area and Copenhagen (Appendix Table 3). In 
addition, the share of patients who were in hospital or long-term care during all 90 days before the index 
day was higher in Oslo (11%) Copenhagen (7%) compared to the Helsinki area (1%).  
6.2 Mortality  
Unadjusted 30-day mortality rates were higher in Oslo and Stockholm than in the Helsinki area and 
Copenhagen (Appendix Table 4). Especially among patients over 74 years of age, the mortality rates were 
higher in these two cities compared to Copenhagen (first 60 days) and the Helsinki area during the whole 
year follow-up period (Figure 8). Age- and gender-standardised 30-day mortality was highest in 
Stockholm, and the difference when compared to the Helsinki area was significant. When adjusting for the 
previous use of services before the index day (model 2), the three mortality indicators were even somewhat 
lower in Oslo and Copenhagen than in the Helsinki area (Table 6). When comorbidity was used for risk- 
adjustment (model 3), the difference between Copenhagen, the Helsinki area and Stockholm was not 
significant. The mortality figures were rather stable during the study period; while only in the Helsinki area 
did the one-year mortality vary between the years (Figure 9). 
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Figure 8. Daily share of patients who died after index day, ischemic stroke patients. 
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Table 6. Risk adjusted performance indicators, ischemic stroke
# 
 
Value min95 max95 Value min95 max95 Value min95 max95 Value min95 max95
30 -day mortality
Model 1 0.057 0.036 0.078 0.054 0.048 0.060 0.064 0.059 0.070 0.068 0.066 0.071
Model 2 0.034 0.022 0.047 0.054 0.048 0.060 0.045 0.041 0.049
Model 3 0.059 0.037 0.082 0.054 0.048 0.060 0.062 0.058 0.065
Model 4 0.039 0.024 0.053 0.054 0.048 0.060
90-day mortality
Model 1 0.119 0.087 0.150 0.077 0.070 0.084 0.092 0.085 0.099 0.101 0.098 0.105
Model 2 0.069 0.051 0.088 0.077 0.070 0.084 0.066 0.061 0.070
Model 3 0.122 0.090 0.155 0.077 0.070 0.084 0.090 0.086 0.093
Model 4 0.078 0.057 0.099 0.077 0.070 0.084
One-year mortality
Model 1 0.188 0.150 0.227 0.122 0.114 0.131 0.152 0.143 0.160 0.160 0.156 0.164
Model 2 0.108 0.086 0.130 0.122 0.114 0.130 0.110 0.104 0.116
Model 3 0.203 0.161 0.244 0.122 0.114 0.130 0.156 0.151 0.161
Model 4 0.124 0.099 0.150 0.122 0.114 0.130
Share of patients discharged home (total )within 90 days
Model 1 0.693 0.652 0.734 0.768 0.757 0.779 0.743 0.729 0.757
Model 2 0.802 0.757 0.846 0.768 0.757 0.778 0.859 0.846 0.873
Model 3 0.695 0.654 0.736 0.769 0.758 0.780
Model 4 0.793 0.749 0.836 0.768 0.757 0.778
Share of patients discharged home (without  help) within 90 days
Model 1 0.524 0.482 0.566 0.652 0.640 0.664 0.603 0.588 0.618
Model 2 0.693 0.647 0.740 0.652 0.641 0.664 0.731 0.717 0.746
Model 3 0.523 0.482 0.564 0.652 0.640 0.664
Model 4 0.691 0.645 0.737 0.652 0.641 0.664
Share of patients institutionalised (90 days)
Model 1 0.143 0.109 0.177 0.125 0.117 0.134 0.134 0.125 0.144
Model 2 0.099 0.077 0.121 0.125 0.117 0.134 0.092 0.086 0.098
Model 3 0.140 0.108 0.173 0.127 0.118 0.135
Model 4 0.097 0.076 0.119 0.125 0.117 0.134
Share of patients institutionalised (one year)
Model 1 0.059 0.037 0.081 0.041 0.036 0.047 0.072 0.065 0.079
Model 2 0.032 0.021 0.044 0.041 0.036 0.046 0.035 0.032 0.038
Model 3 0.055 0.035 0.076 0.041 0.036 0.047
Model 4 0.030 0.019 0.041 0.041 0.036 0.046
Length of  first acute hospital episode
Model 1 14.7 13.0 16.5 9.6 9.5 9.8 13.6 13.2 14.0 7.8 7.7 7.9
Model 2 15.4 13.6 17.3 9.6 9.5 9.8 14.2 13.8 14.6
Model 3 14.4 12.7 16.1 9.6 9.5 9.8 7.9 7.7 8.0
Model 4 15.5 13.7 17.4 9.6 9.5 9.8
Length of  first acute hospital and  rehabilitation  episode
Model 1 15.4 13.4 17.4 20.1 19.5 20.7 22.2 21.5 22.9 14.0 13.8 14.2
Model 2 13.9 12.2 15.7 20.1 19.5 20.7 21.4 20.7 22.1
Model 3 15.3 13.3 17.3 20.1 19.5 20.7 14.1 13.8 14.4
Model 4 13.9 12.1 15.7 20.1 19.5 20.7
Length of first institutional episode
Model 1 24.9 21.8 27.9 25.3 24.5 26.1 26.1 25.3 26.9
Model 2 20.1 17.7 22.4 25.3 24.5 26.1 21.4 20.8 22.0
Model 3 25.3 22.2 28.4 26.0 25.2 26.8
Model 4 19.8 17.5 22.1 25.3 24.5 26.1
Number of days in acute hospital care, one year
Model 1 17.85 15.79 19.90 11.9 11.6 12.2 15.6 15.1 16.1 11.9 11.8 12.1
Model 2 18.50 16.35 20.66 11.9 11.6 12.2 16.6 16.1 17.0
Model 3 17.33 15.33 19.33 11.5 11.2 11.8 11.9 11.7 12.1
Model 4 17.33 15.33 19.33 11.9 11.6 12.2
Number of inpatient  days, one year
Model 1 40.64 34.18 47.11 56.0 53.6 58.5 38.2 36.4 40.0
Model 2 26.59 22.48 30.70 56.8 54.4 59.2 25.4 24.3 26.5
Model 3 41.11 34.61 47.61 56.8 54.4 59.2
Model 4 26.92 22.72 31.11 55.6 53.2 57.9
Number of GP visits ,one year
Model 1 8.19 7.49 8.89 2.6 2.5 2.7 6.4 6.1 6.7 5.9 5.8 6.0
Model 2 9.03 8.20 9.87 2.6 2.5 2.7 6.7 6.4 7.0
Model 3 8.57 7.83 9.30 2.7 2.6 2.8 6.3 6.1 6.4
Model 4 9.48 8.58 10.37 2.6 2.5 2.7
Number of other doctor  visits,one year 
Model 1 8.97 7.98 9.97 6.9 6.6 7.2 2.8 2.5 3.0 6.2 6.6 6.4
Model 2 9.13 8.08 10.17 6.9 6.6 7.2 3.0 2.7 3.3
Model 3 9.33 8.30 10.36 6.9 6.6 7.2 6.8 6.6 7.0
Model 4 9.73 8.64 10.83 6.9 6.6 7.2
Number of home help  visits, one year
Model 1 113.5 71.4 155.6 32.3 29.3 35.2 70.7 64.9 76.5
Model 2 40.0 25.8 54.2 27.0 24.6 29.4 32.9 30.2 35.6
Model 3 133.9 84.6 183.2 39.3 35.7 42.9
Model 4 41.7 27.0 56.5 32.3 29.4 35.1
Cost of  first  acute hospital  episode
Model 1 13021 11468 14575 8518 8355 8680 12042 11710 12374 6912 6820 7004
Model 2 13652 12013 15290 8559 8396 8722 12666 12315 13017
Model 3 12755 11240 14271 8336 8178 8495 6960 6838 7081
Model 4 13745 12100 15390 8517 8355 8679
Cost of  first  acute and rehabilitation hospital episode
Model 1 12778 11271 14286 10823 10660 11113 13909 13542 14276 8286 8185 8387
Model 2 12489 11025 13954 10995 10766 11224 14144 13770 14518
Model 3 12595 11115 14074 10765 10541 10988 8356 8223 8490
Model 4 12486 11028 13945 10885 10658 11111
Cost of  first institutional  episode
Model 1 14912 13254 16569 11948 11697 12198 14667 14299 15035
Model 2 13827 12306 15347 12083 11830 12336 13866 13523 14208
Model 3 14888 13238 16537 11981 11730 12231
Model 4 13782 12272 15292 11945 11696 12194
One-year cost
Model 1 40997 36682 45312 24223 23587 24859 30017 29081 30952
Model 2 30197 27111 33284 24382 23748 25015 22942 22263 23621
Model 3 41564 37233 45895 24619 23975 25263
Model 4 31523 28306 34739 24160 23534 24787
# Risk adjustment variables  includes also year indicators  
Stockholm  2009/2011-
2014 (n=11632-20404)
Copenhagen 2014 
(n=397)
Helsinki area 2009-
2014 (n=5350)
Oslo 2009-2013/2014 
(n=3776-4289)
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Figure 9. Risk-adjusted (model 1) for 30-day and one-year mortality, 2009–2014, ischemic stroke patients 
6.3 Discharge to home 
Using the state diagram we were able to describe unadjusted share of patients being at home before and 
after the index day. Figure 10 describes the daily share of patients over 74 years of age that were at home 
during one-year periods before and after the index day. Before the onset of stroke, the share was somewhat 
higher in the Helsinki area than in the two other cities. In the Helsinki area, patients also returned home 
more quickly. The picture is quite different when we consider the patients who were at home without 
home-help services (Figure 11). The share of patients at home without home help before stroke was clearly 
lower in Oslo and Copenhagen than in the Helsinki area. Use of home help services was more frequent in 
the two cities during 90 days prior to the index date (Appendix Table 3). For example, one week before the 
index day 45% of patients (over 74 years of age) in Copenhagen and 25% patients in Oslo received home 
help services compared to only 3% in the Helsinki area.     
In the Helsinki area, the age- and sex-standardised share of patients discharged to home within 90 days 
was almost 8 percentage points higher than in Copenhagen and about 2 percentage points higher than in 
Oslo.  The correspondence figure for discharges to home without help was even higher (13 and 5 
percentage points) in the Helsinki area compared to Oslo and Copenhagen. However, when the differences 
in the utilisation of services before the onset of stroke (model 2) are taken into account (model 2), the share 
of patients permanently discharged to home was about 8 percentage points higher in Oslo compared to the 
Helsinki areas for all home discharges and about 8 percentage points higher for discharges without home 
help (Table 6). The adjusted shares (models 2 and 4) in Copenhagen were also somewhat higher than in the 
Helsinki area, but the differences were not statistically significant. During the study period, though, Oslo 
reached the level of the Helsinki area in age- and sex-standardised shares (Figure 12).     
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Figure 10. Daily share of patients at home before and after onset of stroke, ischemic stroke patients over 
74 years of age. 
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Figure 11. Daily share of patients at home without help before and after onset of stroke, ischemic stroke 
patients over 74 years of age. 
 
6 Ischemic stroke 
THL — Discussion paper 22/2018 31 
Performance comparison of patient 
pathways in Nordic capital areas 
0.4
0.5
0.6
0.7
0.8
2009 2010 2011 2012 2013 2014
Year
 total home, Helsinki area  home without help, Helsinki area
 total home, Oslo  home without help, Oslo
 total home, Copenhagen  home without help, Copenhagen
Figure 12. Risk-adjusted (model 1) share of patients discharged to home with and without home help 
within 90 days, ischemic stroke patients  
6.4 Institutionalisation 
Since the share of patients over 74 years of age at home before the onset of stroke was highest in the 
Helsinki area, the share of patients at institutions was lowest in the area as well (Figure 13). After the onset 
of stroke, the share of patients in institutions in the Helsinki area was lower than in Copenhagen and Oslo, 
but the differences were smaller than before the onset of the disease and the relative change in the share of 
patients in institutions before and after stroke was highest in the Helsinki area. This is reflected in the risk-
adjusted (model 2) share of institutionalised patients after 90 days and one year after the index day (Table 
6). In the Helsinki area, the 90-day share was about 3 percentage points and the one-year share about 1 
percentage point higher than in Oslo and Copenhagen (insignificant). The differences between Oslo and the 
Helsinki area were rather stable over time, except for 2012, when there was a clear reduction in the share of 
90-day institutionalisations in the Helsinki area (Figure 14). 
6.5 Use and cost of services 
The structural differences between the areas in the use of outpatient doctor’s services was similar as 
with care or AMI and ACS patients, with the exception that among stroke patients, the number of GP visits 
were also highest in Copenhagen and the figures for Stockholm were closer to the number of visits in Oslo. 
Thus, the total number of all doctor visits was much higher in Copenhagen, and in Stockholm the total 
figures were also higher than for the two other areas. Again, the use of GP services in Oslo increased after 
2009 (Figure 15). Home help services were provided more often to patients in Copenhagen and Oslo than 
in the Helsinki area in all risk adjustment specifications: even the figures adjusted for previous use of 
services (model 2) were slightly higher in Oslo and Copenhagen than in the Helsinki area (Table 6).     
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Figure 13. Daily share of patients in institutional care before and after stroke, ischemic stroke 
patients over 74 years of age. 
 
 
The LOS of inpatient care given during the first acute episode was shortest in Stockholm. When 
inpatient rehabilitation was added to the first acute episode, the LOS was lowest in Stockholm and 
Copenhagen. In Oslo, the LOS during the first acute episode was longer than in the Helsinki area, but when 
rehabilitation admissions were also taken into account the difference between the Helsinki area and Oslo 
diminished (Table 6).  In the Helsinki area, the use of care given at health centres during the first hospital 
episode increased after 2012. Except for this change, the annual changes in the LOS during the first acute 
hospital episode and the following inpatient rehabilitation period were minor in the three areas (Figure 16). 
The risk-adjusted (models 1 and 2) number of all inpatient days during the first institutional episode was 
about the same in the three areas but the number of inpatients days during one year was lower in Oslo and 
Copenhagen than in the Helsinki (Table 6). But since stroke patients in Oslo and Copenhagen used more 
expensive acute hospital care, the adjusted cost for care during the first hospital episode were somewhat 
higher in the two cities compared to the Helsinki area. Again, the one-year costs were sensitive to the risk-
adjusting method. Age- and sex-standardised one-year costs were over 15000 € per patient higher in 
Copenhagen than in the Helsinki area and 10000 € higher than in Oslo. The main reason for the higher cost 
in Copenhagen had to do with the greater use of acute hospital care as well as ambulatory and home help 
services. When model 2 was used for risk-adjustment, the difference between Copenhagen and Helsinki 
was reduced to 6000 € and the difference between Copenhagen and Oslo reduced to 7000 € (Table 6). 
During the years 2009–2013, the adjusted (model 2) total one-year costs were about 25 000 € in the 
Helsinki area and about the same level as in Copenhagen in 2014 (Figure 17). In 2014, they decreased in 
Helsinki by 5000 € per patient. 
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Figure 14.  Risk-adjusted (model 2) share of institutionalised patients after 90 days and 
one year, ischemic stroke patients. 
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Figure 15. Risk-adjusted (model 1) number of visits to a doctor during one year after ischemic stroke. 
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Figure 16. Risk-adjusted (model 1) length of stay during first acute hospital episode with and without 
rehabilitation, ischemic stroke patients. 
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Figure 17. Risk-adjusted (model 2) cost during first hospital episode and one year, ischemic stroke 
patients. 
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7 Hip fracture 
7.1 Patient structure 
The number of operated hip fracture patients varied between the areas less than the number of 
AMI/ACS patients but more than the number of ischemic stroke patients. The age- and sex-standardised 
number of hip fracture patients per 10 000 people was in the Helsinki area 8.8 (varying over the years from 
8.0 to 9.2), in Stockholm 12.5 (11.5–13.2), in Copenhagen 11.5 (2014) and in Oslo 14.1 (13.2–15.4). 
Again, the patients in Oslo and Stockholm were older compared to those in the Helsinki area and 
Copenhagen (Appendix Table 4). In the three areas where the data on all institutional care was available, 
16–28% of the patients were in hospital or long-term care for all 90 days before the index day. We 
conducted a separate analysis using data where those institutionalised persons were excluded (Table 8 and 
Appendix Table 5). This exclusion was not applied in the original EuroHOPE cohort, but was similar to the 
one used in the Finnish PERFECT project aiming to make the patient cohort more homogenous (Sund et al. 
2011). Since an important performance measure is how quickly patients are discharged home, it is 
reasonable to also consider only non-institutionalised patients before hip fracture. 
7.2 Mortality  
As expected, the development of mortality was somewhat lower among non-institutionalised patients 
compared to all patients in the three areas (Figure 18). In general, the risk-adjusted mortality figures were 
quite similar in the Helsinki area, Oslo and Stockholm among all hip fracture patients and there were no 
clear time trends in terms of 30-day and one-year mortalities (Figure 19). In Copenhagen, all risk-adjusted 
mortality figures were higher than in other areas, and in some measures the confidence intervals did not cut 
(Table 7).  
The analysis restricted to non-institutionalised patients yielded roughly similar results, but now the risk-
adjusted 30-day mortality figures were 2% lower in Oslo than in the Helsinki area (Table 8). Again, the 30-
day figures were highest in Copenhagen, but the 90-day and one-year mortality differences between the 
three areas varied according to the risk-adjusted method being used: model 2 showed Copenhagen having 
approximately the same mortality rates as Helsinki and Oslo, whereas the other models showed higher 
mortality rates in Copenhagen. The time trend showed that the modestly increasing trend in 30-day 
mortality in Oslo from the year 2010 was paralleled by a decreasing trend in the Helsinki area. During the 
years 2013 and 2014, the figures were almost identical (Figure 20). 
7.3 Discharge to home 
Like stroke patients, we assessed the share of patients at home before and after the index day using a 
state diagram. Figure 21 describes the daily share of non-institutionalised hip fracture patients who were at 
home in one-year time intervals before and after the index day. Note that the share was quite similar 
between the areas. But the picture was again quite different when we considered the patients who were at 
home without home help services (Figure 22). The share of patients who were at home before hip fracture 
was again lowest in Copenhagen followed by Oslo, while highest in the Helsinki area, because the use of 
home help services was more frequent in the former two cities (Appendix Table 5). One week before the 
index day, 41% of patients in Copenhagen and 30% of patients in Oslo received home help services 
compared to a mere 16% in Helsinki.   
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Figure 18. Daily share of patients who died after index day, hip fracture patients. 
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Figure 19. Risk-adjusted (model 1) 30-day and one-year mortality, all hip fracture patients.  
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Table 7. Risk adjusted performance indicators, hip fracture, all patients
 #
Value min95 max95 Value min95 max95 Value min95 max95 Value min95 max95
30 -day mortality
Model 1 0.116 0.081 0.150 0.073 0.066 0.080 0.066 0.059 0.072 0.064 0.061 0.068
Model 2 0.100 0.070 0.129 0.073 0.066 0.080 0.059 0.053 0.065
Model 3 0.127 0.090 0.165 0.073 0.066 0.080 0.065 0.060 0.070
Model 4 0.108 0.076 0.140 0.073 0.066 0.081
90-day mortality
Model 1 0.174 0.137 0.210 0.131 0.121 0.140 0.125 0.116 0.133 0.121 0.117 0.126
Model 2 0.149 0.118 0.179 0.131 0.121 0.140 0.111 0.104 0.119
Model 3 0.201 0.160 0.243 0.131 0.121 0.140 0.122 0.115 0.128
Model 4 0.171 0.137 0.206 0.131 0.122 0.141
One-year mortality
Model 1 0.278 0.236 0.321 0.229 0.217 0.240 0.234 0.222 0.245 0.230 0.223 0.236
Model 2 0.239 0.204 0.274 0.229 0.217 0.240 0.212 0.202 0.222
Model 3 0.311 0.265 0.357 0.229 0.217 0.240 0.233 0.225 0.241
Model 4 0.272 0.232 0.311 0.230 0.218 0.241
Share of patients discharged to home (total )within 90 days
Model 1 0.547 0.507 0.587 0.570 0.556 0.583 0.510 0.496 0.524
Model 2 0.622 0.584 0.660 0.570 0.558 0.581 0.591 0.578 0.603
Model 3 0.497 0.462 0.532 0.570 0.557 0.583
Model 4 0.582 0.547 0.617 0.568 0.557 0.579
Share of patients discharged home (without  help) within 90 days
Model 1 0.244 0.212 0.277 0.356 0.343 0.369 0.309 0.296 0.322
Model 2 0.337 0.299 0.374 0.356 0.344 0.367 0.371 0.359 0.383
Model 3 0.217 0.188 0.246 0.356 0.343 0.368
Model 4 0.319 0.284 0.355 0.352 0.341 0.364
Share of patients institutionalized (90 days)
Model 1 0.238 0.199 0.277 0.263 0.250 0.275 0.321 0.309 0.334
Model 2 0.201 0.171 0.231 0.263 0.252 0.274 0.258 0.249 0.266
Model 3 0.284 0.239 0.329 0.263 0.251 0.275
Model 4 0.211 0.180 0.242 0.264 0.253 0.275
Share of patients institutionalized (one year)
Model 1 0.116 0.088 0.144 0.163 0.152 0.173 0.219 0.207 0.231
Model 2 0.101 0.078 0.123 0.163 0.154 0.172 0.166 0.158 0.173
Model 3 0.143 0.109 0.177 0.163 0.152 0.173
Model 4 0.106 0.082 0.129 0.164 0.154 0.173
Length of  first acute hospital episode
Model 1 18.8 17.8 19.9 9.2 9.0 9.5 10.2 10.0 10.4 7.3 7.2 7.4
Model 2 17.7 16.8 18.7 9.2 9.0 9.5 10.3 10.1 10.6
Model 3 18.8 17.8 19.8 9.2 9.0 9.5 7.8 7.7 7.9
Model 4 17.7 16.8 18.6 9.2 9.0 9.5
Length of  first acute hospital and  rehabilitation  episode
Model 1 28.9 26.6 31.2 30.6 29.9 31.3 30.5 29.7 31.3 16.3 16.1 16.4
Model 2 26.2 24.2 28.2 30.6 29.9 31.3 29.8 29.0 30.6
Model 3 29.1 26.8 31.4 30.6 29.9 31.3 16.5 16.3 16.7
Model 4 26.8 24.7 28.8 30.6 29.9 31.2
Length of first institutional episode
Model 1 44.0 41.0 46.9 44.6 43.7 45.5 47.6 46.7 48.5
Model 2 39.8 37.4 42.2 44.3 43.5 45.1 42.4 41.7 43.1
Model 3 47.5 44.3 50.6 44.4 43.5 45.3
Model 4 41.1 38.6 43.5 44.2 43.4 45.0
Number of days in acute hospital care, one year
Model 1 21.8 20.2 23.4 11.4 11.1 11.8 11.6 11.3 11.8 11.3 11.1 11.5
Model 2 19.1 17.6 20.6 11.4 11.1 11.7 12.0 11.7 12.2
Model 3 21.5 19.9 23.1 11.4 11.1 11.8 11.9 11.6 12.1
Model 4 18.8 17.3 20.3 11.4 11.1 11.7
Number of inpatient  days, one year
Model 1 101.7 90.6 112.7 120.9 117.1 124.7 132.7 128.7 136.8
Model 2 85.4 76.8 94.0 118.2 115.0 121.4 105.6 102.8 108.4
Model 3 118.8 106.0 131.6 118.9 115.4 122.5
Model 4 91.7 82.6 100.8 117.0 113.8 120.2
Number of GP visits ,one year
Model 1 8.2 7.6 8.9 1.9 1.8 2.0 3.0 2.8 3.2 3.0 2.9 3.1
Model 2 9.2 8.4 10.1 1.9 1.8 2.0 3.3 3.1 3.5
Model 3 7.6 6.9 8.2 1.9 1.8 2.1 3.1 2.9 3.2
Model 4 8.7 7.9 9.5 1.9 1.8 2.0
Number of other doctor  visits,one year 
Model 1 7.1 6.4 7.8 5.3 4.9 5.6 0.7 0.7 0.8 4.7 4.6 4.9
Model 2 6.8 6.1 7.5 5.2 4.9 5.5 0.8 0.7 0.9
Model 3 6.9 6.2 7.6 5.3 5.0 5.6 4.7 4.5 4.9
Model 4 6.8 6.2 7.5 5.3 5.0 5.6
Number of home help  visits, one year
Model 1 111.7 84.5 138.8 75.1 69.8 80.3 107.6 100.7 114.5
Model 2 73.5 56.6 90.5 75.1 70.3 79.9 91.0 85.3 96.8
Model 3 115.2 87.3 143.2 75.1 69.9 80.3
Model 4 73.0 56.2 89.8 75.1 70.3 79.9
Cost of  first  acute hospital  episode
Model 1 14047 13579 14515 10029 9918 10139 10382 10266 10498 8783 8737 8830
Model 2 13590 13139 14040 10030 9922 10139 10438 10322 10554
Model 3 14019 13554 14484 10029 9918 10139 9046 8983 9108
Model 4 13584 13134 14034 10030 9922 10139
Cost of  first  acute  and rehabilitatiin hospital  episode
Model 1 16450 15761 17138 14862 14676 15047 14969 14747 15190 10765 10707 10823
Model 2 15547 14923 16171 14861 14678 15044 14862 14649 15075
Model 3 16499 15806 17192 14861 14678 15044 11094 11009 11180
Model 4 15684 15050 16319 14860 14678 15042
Cost of  first institutinal  episode
Model 1 19461 18714 20209 17695 17482 17908 18449 18235 18664
Model 2 18238 17587 18888 17682 17486 17877 17488 17300 17676
Model 3 20197 19423 20971 17686 17479 17892
Model 4 18495 17833 19157 17678 17484 17872
One- year cost
Model 1 44920 41851 47988 42219 44025 42933 45973 44964 46982
Model 2 37985 35571 40400 42938 42152 43723 39998 39226 40771
Model 3 59024 53377 64670 42995 42131 43858
Model 4 39132 36635 41628 42864 42086 43643
# Risk adjustment variables  includes also year indicators 
Stockholm  2009/2011-
2014 (n=8803-15328)
Copenhagen 2014 
(n=471)
Helsinki area 2009-2014 
(n=4523)
Oslo 2009-2013/2014 
(n=4093-4600)
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Table 8. Risk adjusted performance indicators, hip fracture, non-institutionalised patients 
# 
Value min95 max95 Value min95 max95 Value min95 max95
30 -day mortality
Model 1 0.112 0.085 0.138 0.065 0.058 0.073 0.047 0.041 0.054
Model 2 0.088 0.067 0.108 0.065 0.058 0.073 0.043 0.037 0.049
Model 3 0.128 0.098 0.158 0.065 0.058 0.073
Model 4 0.107 0.082 0.132 0.065 0.058 0.073
90-day mortality
Model 1 0.133 0.108 0.158 0.110 0.101 0.120 0.102 0.093 0.112
Model 2 0.104 0.085 0.122 0.110 0.101 0.120 0.096 0.087 0.104
Model 3 0.156 0.127 0.184 0.110 0.101 0.120
Model 4 0.127 0.104 0.15 0.110 0.101 0.120
One-year mortality
Model 1 0.234 0.203 0.264 0.198 0.185 0.210 0.195 0.182 0.208
Model 2 0.191 0.167 0.215 0.198 0.185 0.210 0.186 0.174 0.198
Model 3 0.263 0.23 0.297 0.198 0.186 0.210
Model 4 0.231 0.203 0.26 0.198 0.187 0.210
Share of patients discharged home (total )within 90 days
Model 1 0.641 0.611 0.670 0.679 0.665 0.694 0.681 0.665 0.696
Model 2 0.738 0.707 0.769 0.679 0.666 0.693 0.718 0.702 0.733
Model 3 0.604 0.577 0.631 0.679 0.666 0.693
Model 4 0.687 0.659 0.716 0.678 0.665 0.691
Share of patients discharged home (without  help) within 90 days
Model 1 0.277 0.252 0.303 0.422 0.407 0.437 0.409 0.393 0.425
Model 2 0.388 0.358 0.418 0.422 0.409 0.435 0.455 0.440 0.470
Model 3 0.252 0.229 0.276 0.422 0.408 0.436
Model 4 0.368 0.339 0.396 0.419 0.405 0.432
Share of patients institutionalised (90 days)
Model 1 0.171 0.144 0.199 0.169 0.158 0.181 0.169 0.157 0.181
Model 2 0.116 0.098 0.135 0.169 0.158 0.181 0.145 0.135 0.155
Model 3 0.205 0.173 0.238 0.169 0.158 0.181
Model 4 0.143 0.121 0.165 0.170 0.159 0.181
Share of patients institutionalised (one year
Model 1 0.065 0.048 0.083 0.082 0.073 0.091 0.086 0.076 0.096
Model 2 0.042 0.031 0.053 0.082 0.074 0.090 0.072 0.064 0.080
Model 3 0.082 0.06 0.104 0.082 0.074 0.091
Model 4 0.054 0.041 0.068 0.082 0.074 0.091
Length of  first acute hospital episode
Model 1 19.3 18.5 20.0 9.3 9.1 9.6 11.5 11.2 11.7
Model 2 18.6 17.9 19.3 9.3 9.1 9.6 12.2 11.9 12.5
Model 3 19.3 18.5 20.0 9.3 9.1 9.6
Model 4 18.6 18.0 19.3 9.3 9.1 9.6
Length of  first acute hospital and  rehabiltation  episode
Model 1 31.4 29.6 33.2 31.4 30.7 32.2 33.7 32.8 34.5
Model 2 28.8 27.2 30.4 31.4 30.6 32.1 32.6 31.8 33.4
Model 3 32.2 30.4 34.1 31.4 30.6 32.1
Model 4 29.5 27.8 31.1 31.4 30.6 32.1
Length of first institutional episode
Model 1 39.0 36.8 41.1 38.6 37.7 39.5 38.0 37.0 38.9
Model 2 33.9 32.1 35.7 38.4 37.6 39.3 35.7 34.8 36.6
Model 3 41.4 39.0 43.7 38.5 37.6 39.3
Model 4 35.6 33.7 37.6 38.4 37.5 39.2
Number of days in acute hospital care, one year
Model 1 22.5 21.2 23.8 11.7 11.4 12.0 12.9 12.6 13.3
Model 2 20.3 19.2 21.5 11.7 11.3 12.0 13.0 12.6 13.3
Model 3 22.3 21.1 23.5 11.7 11.4 12.0
Model 4 20.0 18.9 21.1 11.7 11.3 12.0
Number of inpatient  days, one year
Model 1 85.3 77.6 93.0 93.0 89.5 96.5 88.8 85.0 92.7
Model 2 64.8 59.2 70.5 91.2 88.0 94.4 76.9 73.8 80.1
Model 3 98.4 89.3 107.6 91.5 88.2 94.9
Model 4 72.2 65.9 78.5 90.3 87.1 93.5
Number of GP visits ,one year
Model 1 7.9 7.4 8.4 2.1 1.9 2.2 4.1 3.9 4.4
Model 2 9.0 8.3 9.6 2.1 1.9 2.2 4.5 4.2 4.7
Model 3 7.6 7.1 8.1 2.1 1.9 2.2
Model 4 8.7 8.1 9.3 2.1 1.9 2.2
Number of other doctor  visits,one year
Model 1 7.9 7.4 8.5 5.7 5.3 6.0 1.0 0.9 1.1
Model 2 7.9 7.4 8.5 5.6 5.3 6.0 1.0 1.0 1.1
Model 3 7.9 7.3 8.5 5.7 5.3 6.1 1.1
Model 4 7.7 7.1 8.3 5.7 5.3 6.0
Number of home help  visits, one year
Model 1 137.6 114.3 160.8 88.6 82.5 94.7 123.6 115.3 131.9
Model 2 90.4 75.7 105.1 88.6 82.8 94.3 91.9 86.0 97.8
Model 3 152.6 126.8 178.4 88.6 82.5 94.7
Model 4 89.8 75.3 104.4 88.6 82.9 94.3
Cost of  first  acute hospital  episode*
Model 1 14207 13861 14553 10073 9949 10197 10998 10858 11138
Model 2 13072 13965 13630 10073 9949 10196 11004 10864 11144
Model 3 12994 12680 13307 10073 9949 10196
Model 4 13983 13651 14316 10073 9949 10196
Cost of  first  acute  and rehabilitatiin hospital  episode
Model 1 17084 16553 17615 15071 14868 15274 16032 15794 16271
Model 2 16311 15816 16806 15069 14867 15270 15811 15580 16042
Model 3 17284 16744 17824 15069 14867 15271
Model 4 16482 15979 16986 15068 14867 15269
Cost of  first institutional  episode
Model 1 18625 18052 19197 16526 16304 16748 16902 16653 17150
Model 2 17289 16780 17799 16519 16305 16732 16439 16207 16671
Model 3 19180 18584 19776 16520 16303 16736
Model 4 17701 17175 18227 16516 16305 16728
One-year cost
Model 1 43084 40773 45395 37807 36921 38693 37136 36120 38152
Model 2 34777 33031 36523 37629 36827 38431 33154 32324 33984
Model 3 46802 44217 49388 37678 36826 38530
Model 4 36415 34559 38270 37555 36761 38349
# Risk adjustment variables  includes also year indicators  
Copenhagen 2014 
(n=396)
Helsinki area 2009-
2014 (n=3741)
Oslo 2009-2013/2014 
(n=2929-3306)
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Figure 20. Risk-adjusted (model 1) 30-day and one-year mortality, non-institutionalised hip fracture 
patients.  
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Figure 21. Share of patients at home before and after hip fracture, non-institutionalised patients. 
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Figure 22. Share of patients at home without help before and after hip fracture, non-institutionalised 
patients. 
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Figure 23. Risk-adjusted (model 1) share of patients discharged to home with and without home help 
within 90 days, non-institutionalised hip fracture patients. 
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Figure 24. Risk-adjusted (model 2) share of institutionalised patients after 90 days and one year, non-
institutionalised (before fracture) patients. 
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Figure 25. Risk-adjusted (Model 1) number of visits to a doctor (one year), all hip fracture patients. 
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Figure 26. Risk-adjusted (model 1) length of stay during first acute hospital episode with and without 
rehabilitation, all hip fracture patients 
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Figure 27. Risk-adjusted (model 1) length of stay during the first institutional episode and total one-year 
number of inpatient days, non-institutionalised hip fracture patients.  
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Figure 28. Risk-adjusted (Model 1) cost during first hospital episode and after one year, non-
institutionalised hip fracture patients. 
Even among the non-institutionalised patients, the two risk-adjusted methods gave different results in 
terms of the share of patients discharged to home when comparing Copenhagen to the Helsinki area and 
Oslo (Table 7). When model 1 was used for risk-adjustment, the shares were about the same in the three 
areas for total discharges, but clearly lowest in Copenhagen for discharges without home help. When model 
2 was used for risk-adjustment, the shares were about 3-4 percentage points higher in Oslo compared to 
Helsinki. According to the most comprehensive risk-adjustment (model 4), the shares of total discharges 
were the same in the Helsinki area and Copenhagen, but discharges without home help in Helsinki were 5 
percentage points higher. The risk-adjusted shares have increased in the Helsinki area, whereas in Oslo they 
have even somewhat decreased (Figure 23).    
7.4 Institutionalisation 
After hip fracture, the share of non-pre-institutionalised patients who were still in institutional care after 
90 days was 14.4% in Copenhagen, 16.9% in the Helsinki area and 18% in Oslo (Appendix Table 5). The 
corresponding figures after one year were 6.6% in Copenhagen, 8.2% in the Helsinki area and 9.2% in 
Oslo. Again, the comparison between Helsinki, Oslo and Copenhagen varied according to the risk -
adjustment: for 90- day institutionalisation, model 1 gave approximately the same shares for the three areas, 
whereas model 2 gave a rate more than 2 percentage points higher for the Helsinki area compared to Oslo 
and approximately 5 percentage points higher for Copenhagen (Table 8). The difference between Helsinki 
and Oslo was due to figures from earlier years of the study period; during the years 2009–2010, both shares 
were clearly higher in the Helsinki area, but afterwards the shares decreased in Helsinki and increased in 
Oslo such that they reached the same level in both areas after 2011 (Figure 24). In Copenhagen, the shares 
of institutionalised patients were lower compared to Helsinki when model 2 and 4 were used for risk-
adjustment.  
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7.5 Use and cost of services 
The pattern of doctor visits was similar to the care of stroke patients. In Copenhagen, the number of GP 
visits (all hip fracture patients) during one year (8.2) was almost three times greater than in Oslo and 
Stockholm (2.9) and more than four times greater than in the Helsinki area (1.9). The other type of doctor 
visits were used more often in Copenhagen (7.1), the Helsinki area (5.3) and Stockholm (4.5) compared to 
Oslo (0.7) (Appendix Table 5). The risk- adjustment did not affect the comparisons, and likewise the 
analysis of non-institutionalised patients gave similar results between the three areas. The differences 
between the areas were rather stable during the study period (Figure 25). 
As among stroke patients, the LOS of inpatient care given during first acute episode for all hip fracture 
patients was shortest in Stockholm, even when rehabilitation was included. The LOS during the first 
hospital acute episode was longest in Copenhagen. Both in Oslo and the Helsinki area, the LOS for acute 
care decreased during the study period (Figure 26). When rehabilitation admissions were taken into 
account, the length of stay somewhat decreased in the Helsinki area and increased in Oslo (Figure 26). 
Among the non-institutionalised hip fracture patients, the LOS during the first institutional episode as 
well as the total number of inpatient days during first year were about the same in Copenhagen, the 
Helsinki area and Oslo when model 1 was used for risk-adjustment (Table 8). But the time trends in one-
year inpatient days were different between Oslo and Helsinki (Figure 27). Using model 2 for risk- 
adjustment yielded somewhat shorter figures for both measures in Copenhagen and Oslo compared to 
Helsinki (Table 8) 
The adjusted (model 1) cost of the first institutional hospital episode remained at the same level in 
Helsinki and Oslo during the whole study period, which was somewhat lower than in Copenhagen in 2014 
(Figure 28). As a result of greater use of institutional care, the total one-year costs were somewhat higher in 
the Helsinki are compared with Oslo during the years 2009–2010. Subsequently, though, the costs were 
about the same in both areas. Also, these figures proved sensitive to the risk-adjustment model used. When 
model 2 was used instead of model 1, the one-year costs were about 4500 € higher in Helsinki and 1600 € 
higher in Copenhagen compared to Oslo. 
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8 Concluding remarks 
As health care systems may have a different role for primary, secondary, tertiary and social care 
services in different countries, the impact these sectors have on patient outcomes will also vary. To the best 
of our knowledge, this was the first international comparison where register data from primary and long-
term care services were linked with hospital discharge data and mortality registers.  
The study shows that for patients with mixed care pathways across primary, secondary, tertiary and 
social services, a performance comparison with data only from secondary care is not always sufficient for 
international comparisons. Our approach gave us an opportunity to evaluate outcome measures other than 
mere survival, such as measures describing the increase in quick discharges to home (with and without 
help) and the reduction in institutionalisation, which have been an important policy aim in all the Nordic 
countries. Such measures can be used for proxy variables of outcomes if we can assume that the measures 
to some extent reflect the functional status of patients.  
The main methodological conclusions of the study are as follows: 
• The approach studied and presented here is an important extension in the field of health system
performance analysis. With individual-level, routinely collected data, it is possible to considerably
deepen the analysis and enrich the set of outcome and process indicators available for system
performance comparison.
• Using administrative data for international comparisons makes it challenging to obtain
comparative information on the incidence of acute diseases because of national differences in
definitions and coverage of hospital discharge registers.
• Performance analysis requires adequate risk-adjustment to reduce the bias associated with patient
selection. However, the ranking of areas was sensitive to the risk-adjustment method used. In
particular, the previous use of different services (inpatient care, home help) as covariates in the
adjusted models changed the rankings between the areas in terms of the measures describing the
use of inpatient care and costs during a longer follow-up period. By including them, we assumed
that the previous use of services was closely related to the functional ability of patients. However,
we cannot confirm that the functional status of persons living at home with or without help is the
same between the regions, because it may to some extent reflect differences in policy priorities. On
the other hand, the inclusion of these measures in risk-adjustments can be justified if they reflect
changes in the use of services because of the onset of a disease, and these changes can be affected
by treatments or interventions.
 Risk- adjustment based on age, sex and even comorbidities based on medical history of patients
may not be enough for a reliable performance comparison of diseases affecting older persons. Our
study indicates that functional ability (such as measures of activities in daily living) before the
onset of disease is an important predictor of performance and should be taken into account in risk- 
adjustment.
• In this pilot study, it was not possible to pool data from different countries, and risk-adjustment
was done using coefficients calculated from the Helsinki area. In addition, the coverage and years
of availability of the data varied between areas. An analysis will be made more reliable and carried
out more easily if the data can be pooled and if other information, such as socioeconomic
variables, can be included, enabling possibilities to, e.g. evaluate the effect of a reform made in
one area using other areas as control groups (e.g. Häkkinen et al. 2018).
• One special challenge is to increase the comparability of register data describing non institutional
services. For example, home help was not measured using the same units (visits in the Helsinki
area and hours in Oslo and Copenhagen). Our estimates were based on the assumption that one
hour equals two visits.
• Our approach to measuring cost by means of resource use has both strengths and weaknesses. The
main advantage is that we can avoid concerns about differences in cost-accounting systems and
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prices between the countries and producers. It is also an easy way to combine different services. 
The main weakness of this approach is that it does not take into account the differences in the unit 
prices of resource items across countries. For example, the cost of inpatient days or procedures or 
visits may vary owing to differences in inputs (personnel, working time, etc.) and we assume that 
the relative costs of these cost items are the same in both countries. Thus, we compared resource 
use using Finnish estimates on the average unit cost of  services, not actual spending, and our cost 
measure does not necessarily reflect actual expenditure differences. 
 
In spite of the shortcomings, our results indicate some differences between the capital areas, reflecting 
important policy issues:   
 
• The considerable differences in age- and sex-standardised incidence figures as well as in the age 
structure of patients in the disease groups may reflect differences in the role of acute care in 
treating patterns as well as a more aggressive and resource-intensive treatment in Norway and 
Sweden. In Oslo, for example, the age structure of the total population is much younger compared 
to Helsinki and Copenhagen, but the age structure of the patients was much older in Oslo. In Oslo, 
the age- and sex-standardised number of patients per population was also highest in all four disease 
groups. In addition, the share of patients who were permanently institutionalised before the onset 
of their disease was much higher in Oslo than in the Helsinki area. In the Helsinki area, e.g. AMI 
and stroke patients included only patients admitted to Helsinki University Hospital, which has a 
more developed capacity (e.g. possibility to perform PCI or intensive stroke treatments) not 
available in other hospitals (e.g. health centres). 
• The treatment of the diseases was most concentrated on acute hospital care in Copenhagen, where 
the length of the first acute hospital stay was longest (among ACS and hip fracture patients) and 
the one-year use of both inpatient and outpatient acute hospital care services (all patients groups) 
were highest. This could relate to national differences in hospital organisation. 
• In Oslo, the ambulatory services compromised  mainly services  from GPs, while in Copenhagen 
and Stockholm ambulatory services included  both  GPs and hospital outpatient services and in the 
Helsinki area merely hospital outpatient services. In addition, the use of home help services both 
before and after the onset of disease was considerable higher in Copenhagen and Oslo compared to 
the Helsinki area. This may indicate more developed primary and home help services in Norway 
and Denmark compared to Finland and to some extent Stockholm, as assumed based on descriptive 
information on the primary care systems (Häkkinen and Jonsson, 2009). However, these 
differences were not associated with better outcomes in Copenhagen and Oslo compared to 
Helsinki area. 
• Although the mortality figures were sensitive to risk- adjustment, the results indicate higher 
mortality rates in Stockholm among AMI/ACS patients and stroke patients (30-day mortality) and 
in Copenhagen among hip fracture patients. 
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Appendix 1: Costing of services
Service Method Value in 2014
Acute hospital care Based on cost function estimated using  
individual level cost data ( 2014  prices) 
from Helsinki University hospital 
 AMI/ACS
First acute hospital episode:
 M :   C    €= 6705*C BG + C *2073+968*  S - 707  
 CS:   C    €=8440*C BG + C *2100+ 959*  S - 757   
where LOS= length of stay; CABG=1 if coronary artery bypass surgery performed ; PCI =1 if percutaneous coronary intervention  
performed 
One year cost of acute care:
 M :      €= 5400 *C BG365 + 1729* C 365 +  993*  S365_ +917*   S365_  -813
 CS:      €= 6132 *C BG365 + 1851*    365 +  963*  S365_  +876*   S365_  -783
where CABG365=number  coronary artery bypass surgery performed during 365 days; PCI365 =number  percutaneous coronary 
interventions  performed during the 365 days;  LOS365_A=number of  days in acute care during 365 days because  of AMI/ACS;  
LOS365_O numbers days in acute care during 365 days because on non AMI/ACS diagnoses 
STROKE
  882 €/               
Hip fracture
First acute hospital episode
C    €=  1810 *     1 - 1221*S720 + 510*  S+ 5119   
where group1=1, if operation is partial  prosthesis ,=0 if  other operation; S720= 1, if main diagnosis is ICD:10: S72,0 , 0=if ICD:10 
S72.1 or S72,2 ; LOS=length of stay   
One year cost of acute care
C    €  = 5894* R C365 +  284*  S365_  +7 09*  S_  + 1678.326
 where PROC = Number of hip fracture  operations performed during 365 days;  LOS365_H=number of  days in acute care during 
365 days because of  hip fracture;  LOS365_O numbers days in acute care during 365 days  because on non hip fracture 
diagnoses 
Rehabilitation and non specialized 
short term inpatient care. In Helsinki 
area includes short term care (length 
of stay less than 90 days in health 
centres) and care in  psychiatric 
departments 
Standard cost estimates 2011 (Kapiainen 
et al.,2014)
226,2 € /   
 Long term stay in municipal institution Standard cost estimates 2011 (Kapiainen 
et al.,2014)   
202,8 €/   
Outpatient visits of hospital including 
day surgery
Standard cost estimates 2011    (Kapiainen 
et al.,2014)
349.2 €/     
Visits to a specialist. In Helsinki area 
visits to a private specialist
Based on cost function estimates using 
Finnish  individual level cost data (current 
prices)
286.6€/     
Visit to a doctor primary care including 
home visits . In Helsinki area visits to 
health centre doctor and private non 
specialist doctor 
Based on cost function estimates using 
Finnish  individual level cost data (current 
prices)
116, 8 €/     
Home care . In Oslo and Copenhagen 
and assumed  2 visit per hour
Standard cost estimates 2011  
(Kapiainen et al.,2014)
52,0€ /     
Source: Kapiainen S, Väisänen A, Haula T. Terveyden- ja sosiaalihuollon yksikkökustannukset Suomessa vuonna 2011 , Helsinki 2014
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mean sd mean sd mean sd mean sd
mean 65.551 14.194 67.7 12.9 72.3 14.9 72.0 13.5
age under 50 0.133 0.340 0.090 0.286 0.1 0.3 0.058 0.234
age 50-54 0.084 0.277 0.079 0.269 0.064 0.244 0.057 0.232
age 55-59 0.133 0.340 0.102 0.303 0.083 0.276 0.077 0.266
age 60-64$ 0.130 0.337 0.138 0.345 0.095 0.293 0.104 0.306
age 65-69 0.133 0.340 0.133 0.340 0.103 0.304 0.130 0.336
age 70-74 0.103 0.304 0.125 0.331 0.093 0.290 0.114 0.318
 age 75- 79 0.103 0.304 0.122 0.328 0.102 0.302 0.118 0.323
age 80-84 0.080 0.272 0.115 0.319 0.125 0.331 0.129 0.335
age 85-89 0.055 0.228 0.067 0.251 0.139 0.346 0.124 0.330
age over 89 0.045 0.208 0.030 0.170 0.122 0.327 0.088 0.284
Gender* Male 0.662 0.473 0.666 0.472 0.598 0.490 0.630 0.483
Type of AMI* Stemi 0.277 0.448 0.466 0.499 0.382 0.486 0.244 0.429
Non stemi 0.436 0.496 0.469 0.499 0.338 0.473 0.450 0.497
Undefined 0.288 0.453 0.064 0.245 0.279 0.449 0.307 0.461
Cohort year * 2009 0.152 0.191 0.178
2010 0.150 0.185 0.174
2011 0.155 0.173 0.171
2012 0.170 0.169 0.167
2013 0.201 0.158 0.154
2014 1.000 0.172 0.123 0.156
Acute hospital days 3.1 5.4 1.0 4.5 0.6 3.1 2.089
Other inpatient days 2.1 13.1 2.6 12.2 9.2 26.0
Days at home  with home help 10.8 27.5 2.1 10.6 14.3 31.5
Days at home without  home help 74.0 31.0 84.4 17.4 65.9 39.0
0.023 0.148 0.016 0.009 0.088 0.283
Hypertension 0.593 0.492 0.625 0.484 0.682   0.466   
Coronary artery disease 0.085 0.279 0.060 0.238 0.104   0.305   
Atrial fibrillation 0.034 0.181 0.022 0.146 0.064   0.244   
Cardiac insufficiency (heart failure) 0.045 0.208 0.024 0.154 0.068   0.252   
Diabetes mellitus 0.183 0.387 0.210 0.407 0.207   0.405   
Cancer 0.011 0.106 0.026 0.159 0.033   0.179   
COPD and asthma 0.164 0.371 0.153 0.360 0.163   0.370   
Depression 0.127 0.333 0.109 0.311 0.143   0.350   
Parkinson's disease 0.013 0.113 0.015 0.123 0.017   0.128   
Mental disorders 0.050 0.218 0.025 0.157 0.024   0.152   
Stroke 0.023 0.148 0.014 0.119 0.022   0.147   
Performance indicators 
30 -day mortality* 0.042 0.200 0.068 0.252 0.099 0.298 0.096 0.295
90-day mortality* 0.053 0.224 0.083 0.276 0.132 0.338 0.127 0.333
One-year mortality** 0.092 0.289 0.122 0.327 0.215 0.411 0.192 0.394
Share of patients discharged home (total )within 90 days* 0.899 0.302 0.877 0.328 0.769 0.421
Share of patients discharged home (without  help) within 90 days* 0.752 0.432 0.777 0.416 0.625 0.484
Share of patients institutionalized (90 days)* 0.031 0.172 0.021 0.143 0.082 0.275
Share of patients institutionalized (one year)** 0.016 0.126 0.010 0.101 0.056 0.230
Length of  first acute hospital episode* 8.4 9.1 8.4 8.2 6.9 5.6 6.4 5.8
Length of  first acute hospital and  rehabiltation  
episode*
9.1 11.2 10.6 12.6 12.0 18.6 8.0 8.4
Length of first institutional episode* 11.2 17.1 11.8 15.9 15.5 24.5
Number of days in acute hospital care, one year** 12.6 14.7 11.8 13.9 9.7 9.8
Number of days in acute hospital  care and inpatient 
rehabilitation , one year**
14.7 19.4 17.3 24.7 25.6 56.7 15.1 19.4
Number of inpatient  days, one year** 24.2 57.1 23.7 50.5 45.3 94.9
Number of GP visits ,one year** 6.2 6.6 2.6 3.1 7.8 9.2 4.5 6.7
Number of other doctor  visits, one year* 13.3 14.9 6.7 13.7 1.3 3.5 6.6 11.5
Number home help  visits,  one year** 39.4 160.1 21.0 89.8 61.7 179.4
Cost of  first  acute hospital  episode* 8609 9140 9859 8932 7030 5881 6692 6098
Cost of  first  acute and rehabilitation hospital episode* 8744 9423 10352 9401 8137 7485 7061 6404
Cost of  first institutional  episode* 9107 9805 10592 9628 8853 8088
One year cost** 24112 24209 19568 21186 21662 26571
*Oslo: excluded patients with  after mid September in in 2014  ( n=6269)
**Oslo: excluded patients with index day  in 2014 (n=5491)
*** Stockholm: exluded patients with indexday before the  first of July 2011 (n= 9978)
Appendix Table 1. Descriptive statistics  AMI 
Oslo  
2009-2013/2014 
(n=5491-6209)
Stockhom  
2009/2011-2014  
(n=9978-17776)
Number of  days  in  different   care arrangements  
within 90 days before index admission*
Comorbidities based on pervious year use of hospital 
care and prescribed medicines ***
AGE*
Share of patients who were the hospital or long-term care for all 90 days before the index 
admission*
Copenhagen 2014 
(n=622)
Helsinki area  
2009-2014  
(n=3604)
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mean sd mean sd mean sd mean sd
mean 65.0 13.7 67.7 12.8 71.3 14.8 71.4 13.2
age under 50 0.131 0.338 0.086 0.280 0.079 0.270 0.057 0.231
age 50-54 0.089 0.285 0.078 0.267 0.069 0.254 0.060 0.238
age 55-59 0.128 0.335 0.101 0.302 0.090 0.286 0.082 0.275
age 60-64$ 0.146 0.353 0.140 0.348 0.103 0.304 0.110 0.313
age 65-69 0.146 0.353 0.132 0.338 0.109 0.311 0.136 0.343
age 70-74 0.105 0.307 0.130 0.337 0.095 0.293 0.121 0.326
 age 75- 79 0.093 0.291 0.126 0.332 0.100 0.300 0.119 0.324
age 80-84 0.076 0.264 0.113 0.316 0.118 0.323 0.123 0.329
age 85-89 0.049 0.215 0.065 0.247 0.129 0.336 0.114 0.317
age over 89 0.038 0.191 0.028 0.166 0.107 0.309 0.079 0.269
Gender* Male 0.660 0.474 0.660 0.474 0.605 0.489 0.644 0.479
Type of AMI* Stemi 0.208 0.406 0.406 0.491 0.319 0.466 0.212 0.409
Non stemi 0.278 0.448 0.408 0.491 0.274 0.446 0.389 0.488
Undefined 0.212 0.409 0.056 0.231 0.232 0.422 0.266 0.442
Unstable Angina 0.302 0.460 0.130 0.336 0.175 0.380 0.133 0.339
Cohort year * 2009 0.155 0.191 0.171
2010 0.151 0.186 0.170
2011 0.153 0.170 0.168
2012 0.172 0.171 0.155
2013 0.199 0.160 0.158
2014 1.000 0.170 0.122
Acute hospital days 3.13 5.24 0.94 4.68 0.54 3.00 2.01 3.57
Other inpatient days 2.2 13.5 2.5 11.8 8.2 24.7
Days at home  with home help 10.4 27.1 2.0 10.3 13.2 30.6
Days at home without  home help 74.2 30.6 84.6 16.9 68.1 37.8
0.024 0.154 0.016 0.124 0.078 0.268
Hypertension 0.613 0.487 0.640 0.480 0.692 0.462
Coronary artery disease 0.101 0.302 0.064 0.246 0.107 0.309
Atrial fibrillation 0.035 0.184 0.021 0.144 0.061 0.239
Cardiac insufficiency (heart failure) 0.043 0.203 0.024 0.153 0.063 0.243
Diabetes mellitus 0.201 0.401 0.215 0.411 0.210 0.407
Cancer 0.011 0.103 0.024 0.154 0.032 0.177
COPD and asthma 0.173 0.378 0.155 0.361 0.162 0.369
Depression 0.131 0.338 0.110 0.313 0.140 0.347
Parkinson's disease 0.011 0.103 0.015 0.121 0.017 0.129
Mental disorders 0.061 0.239 0.024 0.154 0.022 0.147
Stroke 0.019 0.136 0.015 0.123 0.021 0.144
Performance indicators 
30 -day mortality* 0.035 0.184 0.062 0.241 0.083 0.276 0.084 0.278
90-day mortality* 0.046 0.209 0.077 0.266 0.113 0.317 0.111 0.315
One-year mortality** 0.084 0.277 0.113 0.317 0.186 0.389 0.171 0.377
Share of patients discharged home (total )within 90 days* 0.907 0.291 0.885 0.319 0.798 0.402
Share of patients discharged home (without  help) within 90 days* 0.760 0.428 0.791 0.406 0.663 0.473
Share of patients institutionalized (90 days)* 0.031 0.174 0.020 0.141 0.073 0.261
Share of patients institutionalized (one year)** 0.019 0.136 0.010 0.098 0.051 0.219
Length of  first acute hospital episode* 9.0 8.8 8.2 8.3 6.5 5.3 6.3 5.7
Length of  first acute hospital and  rehabiltation  
admissions*
9.6 10.7 10.2 12.3 11.0 17.7 7.8 8.3
Length of first institutional episode* 11.8 17.0 11.4 15.7 14.1 23.4
Number of days in acute hospital care, one year** 13.5 14.5 11.6 14.1 9.1 9.5 10.9 12.4
Number of days in acute hospital  care and 
inpatient rehabilitation , one year**
15.5 19.0 16.8 24.3 23.7 54.9 14.7 18.9
Number of inpatient  days, one year** 25.6 58.8 23.0 49.9 41.0 90.9
Number of GP visits ,one year** 7.0 6.4 2.7 3.2 8.2 9.2 4.6 6.7
Number of other doctor  visits, one year* 15.3 16.3 6.6 13.0 1.4 3.5 6.7 11.5
Number home help  visits,  one year** 38.1 154.9 19.8 86.3 56.6 176.8
Cost of  first  acute hospital  episode* 9719 8858 9719 9319 6497 5695 6726 6312
Cost of  first  acute  and rehabilitation hospital  
episode*
9860 9095 10166 9739 7474 7212 7073 6622
Cost of  first institutional   episode* 10248 9465 10403 9956 8111 7812
One year cost** 26359 23661 18984 20690 19886 25562
* Oslo: excluded patients with index after September  in  2014 (n=7457)
*** Stockholm: exluded patients with indexday beforethe  first of July 2011  (n=11513)
Appendix Table 2. Descriptive statistics ACS
Share of patients in institution 90 days before ACS*
Comorbidities based on pervious year use of 
hospital care and prescribed medicines***
**Oslo: excluded patients with index day in 2014 ( n=6548)
Copenhagen 2014 
(n=741)
Helsinki area      
2009-2014             
(n=4127)
Oslo                            
2009-2013/2014 
(n=6548-7457)
Stockholm  
2009/2011-2014 
(n=11513-20366)
AGE*
Number of  days  in  different   care 
arrangements  within 90 days before index 
admission*
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mean sd mean sd mean sd mean sd
mean 70.2 14.5 70.2 13.0 75.5 14.0 75.8 12.8
age under 50 0.088 0.284 0.069 0.254 0.054 0.226 0.039 0.193
age 50-54 0.073 0.261 0.049 0.215 0.034 0.181 0.027 0.162
age 55-59 0.058 0.234 0.069 0.253 0.045 0.208 0.043 0.204
age 60-64$ 0.113 0.317 0.105 0.306 0.075 0.263 0.074 0.262
age 65-69 0.139 0.346 0.144 0.351 0.095 0.293 0.107 0.309
age 70-74 0.108 0.311 0.156 0.362 0.106 0.308 0.118 0.322
 age 75-79 0.118 0.323 0.151 0.358 0.115 0.320 0.134 0.340
age 80-.84 0.113 0.317 0.136 0.343 0.166 0.372 0.165 0.371
age 85-89 0.091 0.288 0.090 0.286 0.173 0.378 0.168 0.374
age over 89 0.098 0.298 0.032 0.177 0.138 0.345 0.126 0.332
Gender* Male 0.49 0.50 0.530 0.499 0.486 0.500 0.491 0.500
Cohort year * 2009 0.164 0.178 0.167
2010 0.162 0.174 0.173
2011 0.179 0.169 0.171
2012 0.178 0.182 0.167
2013 0.161 0.179 0.166
2014 1.000 0.157 0.120 0.156
Acute hospital days 3.5 7.5 0.8 3.8 0.4 2.9 2.6 5.2
Other inpatient days 6.8 22.9 1.7 10.0 11.1 28.3
Days at home  with home help 21.5 36.4 1.5 8.7 15.2 32.3
Days at home without  home help 58.1 40.6 86.0 14.4 63.3 40.3
0.071 0.256 0.011 0.104 0.107 0.309
Hypertension 0.63 0.48 0.68 0.47 0.72 0.45
Coronary artery disease 0.03 0.18 0.06 0.24 0.08 0.27
Atrial fibrillation 0.07 0.25 0.09 0.29 0.13 0.33
Cardiac insufficiency (heart failure) 0.02 0.13 0.03 0.17 0.08 0.27
Diabetes mellitus 0.17 0.38 0.19 0.39 0.17 0.38
Cancer 0.02 0.15 0.08 0.27 0.04 0.20
COPD and asthma 0.15 0.35 0.14 0.35 0.14 0.35
Dementia 0.02 0.13 0.02 0.14 0.05 0.21
Depression 0.15 0.36 0.13 0.34 0.18 0.38
Parkinson's disease 0.01 0.10 0.02 0.13 0.02 0.14
Mental disorders 0.06 0.23 0.03 0.18 0.03 0.17
Performance indicators 
30 -day mortality* 0.063 0.243 0.054 0.226 0.095 0.293 0.099 0.298
90-day mortality* 0.113 0.317 0.077 0.267 0.136 0.343 0.146 0.353
One-year mortality** 0.174 0.379 0.122 0.327 0.223 0.416 0.223 0.416
Share of patients discharged home (total )within 90 days* 0.705 0.456 0.768 0.422 0.689 0.463
Share of patients discharged home (without  help) within 90 days* 0.539 0.499 0.652 0.476 0.520 0.500
Share of patients institutionalized (90 days)* 0.144 0.351 0.125 0.331 0.150 0.357
Share of patients institutionalized (one year)** 0.06 0.24 0.04 0.20 0.094 0.292
Length of  first acute hospital episode* 13.2 15.9 9.6 6.9 13.5 12.5 7.7 7.5
Length of  first acute hospital and  rehabiltation  
episode*
16.9 22.4 24.0 26.5 15.2 15.3
Length of first institutional episode* 24.5 31.8 25.3 29.5 28.3 30.6
Number of days in acute hospital care, one year** 15.8 18.4 11.9 10.5 15.4 14.2 11.6 11.9
Number of days in acute hospital  care and 
inpatient rehabilitation , one year**
22.7 29.1 31.4 40.3 44.6 72.4
Number of inpatient  days, one year** 65.0     109.4   33.2 46.8 76.4 117.3
Number of GP visits ,one year** 7.6 6.5 2.6 3.8 6.2 14.0 5.8 8.5
Number of other doctor  visits, one year* 8.8 10.1 6.9 11.4 2.4 70.6 5.7 10.4
Number home help  visits,  one year** 118.4 452.4 32.3 112.6 93.4 114.3
Cost of  first  acute hospital  episode* 11637 14057 8517 6105 11946 11022 6844 6596
Cost of  first  acute  and rehabilitation hospital  
episode*
12476 14946 10887 8516 14309 12671 8529 7533
Cost of  first hospital  episode* 14031 15927 11948 9432 15186 12853
One year cost** 34941 38299 24229 24048 33209 33158
* Oslo: excluded patients with index day after mid September  2014 (n=4389)
Appendix Table 3. Descriptive statistics ischemic stroke 
Share of patients in institution 90 days before stroke
Comorbidities based on pervious year use of 
hospital care and prescribed medicines
**Oslo: excluded patients with index day in 2014 ( n=3776)
*** Stockholm: exluded patients with indexday before the  first of July 2011  (n=11632)
Copenhagen 2014 
(n=397)
Helsinki area  
2009-2014  
(n=5350)
Oslo  
2009-2013/2014 
(n=3776-4289)
Stockhom  
2009/2011-2014  
(n=11632-20404)
AGE*
Number of  days  in  different   care 
arrangements   within 90 days before index 
admission*
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mean sd mean sd mean sd mean sd
mean 78.5 11.7 79.9 10.6 82.3 10.2 82.0 9.9
age 0-54 0.05 0.22 0.019 0.138 0.015 0.120 0.011 0.104
age 55-59 0.04 0.19 0.035 0.183 0.023 0.150 0.020 0.138
age 60-64$ 0.06 0.24 0.053 0.224 0.037 0.190 0.038 0.191
age 65-69 0.08 0.27 0.076 0.265 0.060 0.238 0.059 0.236
age 70-74 0.08 0.28 0.085 0.279 0.065 0.246 0.083 0.276
 age 75- 79 0.16 0.37 0.134 0.340 0.108 0.311 0.116 0.320
age 80-.84 0.18 0.38 0.201 0.401 0.180 0.385 0.192 0.394
age 85-89 0.19 0.39 0.223 0.416 0.258 0.437 0.253 0.434
age over 89 0.16 0.37 0.175 0.380 0.253 0.435 0.229 0.420
Gender* Male 0.29 0.45 0.294 0.456 0.277 0.448 0.303 0.460
Type of  Hip fracture* s720 0.53 0.50 0.604 0.489 0.586 0.493 0.522 0.500
s721 0.40 0.49 0.358 0.479 0.357 0.479 0.391 0.488
s722 0.07 0.26 0.051 0.220 0.055 0.228 0.092 0.290
Cohort year * 2009 0.156 0.191 0.393 0.171
2010 0.168 0.183 0.387 0.169
2011 0.170 0.169 0.375 0.168
2012 0.174 0.180 0.384 0.169
2013 0.173 0.166 0.372 0.163
2014 1.000 0.160 0.110 0.313 0.160
Acute hospital days 3.662 7.505 0.7 3.8 0.4 2.7 2.0 3.9
Other inpatient days 18.705 32.949 20.4 34.8 28.4 40.1
Days at home  with home help 28.310 37.751 11.9 25.8 19.8 35.2
Days at home without  home help 39.323 41.141 57.0 39.6 41.3 43.8
0.159 0.366 0.17 0.38 0.28 0.45
Hypertension 0.658 0.475 0.665 0.472 0.682 0.466
Coronary artery disease 0.034 0.181 0.041 0.198 0.061 0.239
Atrial fibrillation 0.045 0.207 0.057 0.233 0.099 0.298
Cardiac insufficiency (heart failure) 0.025 0.158 0.037 0.188 0.078 0.268
Diabetes mellitus 0.102 0.303 0.153 0.360 0.113 0.317
Cancer 0.017 0.129 0.042 0.200 0.053 0.224
COPD and asthma 0.208 0.406 0.147 0.355 0.154 0.361
Dementia 0.106 0.308 0.198 0.398 0.145 0.352
Depression 0.246 0.431 0.287 0.452 0.298 0.458
Parkinson's disease 0.040 0.197 0.050 0.217 0.040 0.195
Mental disorders 0.072 0.259 0.092 0.289 0.053 0.223
Stroke 0.030 0.170 0.031 0.174 0.066 0.249
Performance indicators 
30 -day mortality* 0.083 0.276 0.073 0.260 0.078 0.268 0.073 0.260
90-day mortality* 0.153 0.360 0.131 0.337 0.143 0.351 0.137 0.344
One-year mortality** 0.251 0.434 0.229 0.420 0.263 0.440 0.252 0.434
Share of patients discharged home (total )within 90 days* 0.575 0.495 0.570 0.495 0.477 0.500
Share of patients discharged home (without  help) within 90 days* 0.278 0.449 0.356 0.479 0.277 0.448
Share of patients institutionalized (90 days)* 0.227 0.419 0.263 0.440 0.343 0.475
Share of patients institutionalized (one year)** 0.121 0.326 0.163 0.369 0.230 0.421
Length of  first acute hospital episode* 15.2 9.1 9.24 7.55 10.35 7.84 7.37 5.37
Length of  first acute hospital and  rehabiltation  
episode*
27.6 24.4 30.6 24.5 31.3 29.3 16.9 11.2
Length of first institutional episode* 41.9 32.4 44.6 32.2 49.4 34.2
Number of days in acute hospital care, one year** 19.4 16.0 11.4 11.7 11.7 9.5 11.3 11.2
Number of days in acute hospital  care and 
inpatient rehabilitation , one year**
35.9 33.9 46.6 44.1 54.2 77.4 24.4 20.9
Number of inpatient  days, one year** 100.8 123.8 120.9 133.4 139.6 144.7
Number of GP visits ,one year** 8.2 7.3 1.9 4.0 2.9 6.5 2.9 5.6
Number of other doctor  visits, one year* 7.1 8.1 5.3 10.6 0.7 1.9 4.5 8.9
Number home help  visits,  one year** 118.2 317.8 75.1 182.0 111.1 233.1
Cost of  first  acute hospital  episode* 12852 4731 10029 3874 10451 4076 8805 2872
Cost of  first  acute  and rehabilitation hospital  
episode*
15641 7340 14862 6491 15180 7854 10955 3745
Cost of  first hospital  episode* 18505 8140 17696 7570 18850 7894
One year cost** 45069 34166 43126 31829 46240 34246
* Oslo: excluded patients with index day after mid September  2014 (n=4600)
Appendix Table  4. Descriptive statistics hip fracture (all patients)
Share of patients in institution 90 days before  AMI*
Comorbidities based on pervious year use of 
hospital care and prescribed medicines***
**Oslo: excluded patients with index day in 2014 ( n=6548)
*** Stockholm: exluded patients with indexday before the  first of July 2011  (n=8803)
Copenhagen 2014 
(n=471)
Helsinki area      
2009-2014             
(n=4523)
Oslo                            
2009-2013/2014 
(n=4093-4600)
Stockhom                      
2009/2011-2014     
(n=8803-15328)
AGE*
Number of  days  in  different   care 
arrangements   within 90 days before index 
admission*
Appendix tables 
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mean 77.23 11.82 79.1 10.6 80.7 10.6
age 0-54 0.06 0.23 0.021 0.142 0.020 0.139
age 55-59 0.04 0.20 0.039 0.194 0.030 0.170
age 60-64$ 0.07 0.26 0.058 0.234 0.048 0.213
age 65-69 0.09 0.28 0.085 0.279 0.076 0.264
age 70-74 0.09 0.28 0.090 0.286 0.077 0.267
 age 75- 79 0.17 0.37 0.142 0.349 0.120 0.325
age 80-.84 0.19 0.39 0.201 0.401 0.184 0.387
age 85-89 0.16 0.37 0.207 0.406 0.243 0.429
age over 89 0.14 0.35 0.157 0.364 0.203 0.402
Gender* Male 0.31 0.46 0.303 0.460 0.293 0.455
Type of  Hip fracture* s720 0.52 0.52 0.608 0.488 0.597
s721 0.40 0.40 0.353 0.478 0.346
s722 0.08 0.08 0.052 0.223 0.055
Cohort year * 2009 0.160 0.196
2010 0.166 0.180
2011 0.169 0.164
2012 0.174 0.179
2013 0.171 0.168
2014 1.000 0.160 0.114
Acute hospital days 3.72 7.33 0.73 3.52 0.53 3.06
Other inpatient days 5.83 15.34 5.92 15.68 4.45 13.78
Days at home  with home help 33.67 38.92 14.44 27.68 27.59 38.84
Days at home without  home help 46.77 40.80 68.90 32.79 57.43 41.77
0.000 0.000 0.000 0.000 0.000
Hypertension 0.66 0.47 0.68 0.47
Coronary artery disease 0.03 0.17 0.04 0.20
Atrial fibrillation 0.05 0.22 0.06 0.23
Cardiac insufficiency (heart failure) 0.03 0.16 0.04 0.19
Diabetes mellitus 0.07 0.26 0.16 0.37
Cancer 0.02 0.13 0.05 0.21
COPD and asthma 0.19 0.39 0.15 0.36
Dementia 0.06 0.24 0.15 0.36
Depression 0.21 0.41 0.26 0.44
Parkinson's disease 0.04 0.18 0.05 0.22
Mental disorders 0.07 0.25 0.08 0.26
Stroke 0.02 0.15 0.03 0.17
Performance indicators 
30 -day mortality* 0.081 0.273 0.065 0.247 0.054 0.227
90-day mortality* 0.119 0.324 0.110 0.313 0.114 0.318
One-year mortality** 0.212 0.409 0.198 0.398 0.213 0.410
Share of patients discharged home (total )within 90 days* 0.672 0.470 0.679 0.467 0.656 0.475
Share of patients discharged home (without  help) within 90 days* 0.318 0.466 0.422 0.494 0.383 0.486
Share of patients institutionalized (90 days)* 0.154 0.361 0.169 0.375 0.181 0.385
Share of patients institutionalized (one year)** 0.066 0.248 0.082 0.274 0.092 0.289
Length of  first acute hospital episode* 15.6 8.7 9.3 7.7 11.5 8.0
Length of  first acute hospital and  rehabiltation  
episode*
30.1 25.4 31.4 24.4 34.3 27.2
Length of first institutional episode* 36.2 30.2 38.6 29.4 39.1 30.8
Number of days in acute hospital care, one year** 20.1 16.2 11.7 10.8 13.1 9.7
Number of days in acute hospital  care and 
inpatient rehabilitation , one year**
39.7 35.2 49.2 45.2 51.0 52.9
Number of inpatient  days, one year** 81.9 ? 93.1 112.6 93.6 116.6
Number of GP visits ,one year** 7.9 7.1 2.1 4.2 4.1 7.3
Number of other doctor  visits, one year* 7.7 8.4 5.7 11.2 1.0 2.2
Number home help  visits,  one year** 140.6 342.1 88.6 194.9 127.8 238.3
Cost of  first  acute hospital  episode* 12993 4547 10073 3950 11049 4152
Cost of  first  acute  and rehabilitation hospital  
episode*
16294 7449 15072 6508 16202 7290
Cost of  first hospital  episode* 17512 8057 16527 7224 17177 7755
One year cost** 42366 33026 37809 28544 38162 30040
* Oslo:Excluded patients with index day after mid September  2014 (n=3306)
Appendix Table 5. Descriptive statistics hip fracture, non-institutionalised patients
Share of patients in institution 90 days before Hip fracture
Comorbidities based on pervious year use of 
hospital care and prescribed medicines
Copenhagen 2014 
(n=396)
Helsinki area  
2009-2014  
(n=3741)
Oslo  
2009-2013/2014 
(n=2929-3306)
AGE*
Number of  days  in  different   care 
arrangements   within 90 days before index 
admission**
**Oslo: Excluded patients with index day in 2014 ( n=2929)
